{"content":"<li class=\"n-box-item date-title\" data-end=\"1562903999\" data-start=\"1562817600\" data-txt=\"Monday, December 23, 2019\">Thursday, July 11, 2019</li><li class=\"n-box-item sa-box-item\" data-id=\"3477305\" data-ts=\"1562884046\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SAVE\" target=\"_blank\">SAVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477305-spirit-airlines-guides-two-q2-benchmarks-below-year-ago-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Spirit Airlines guides two Q2 benchmarks below year-ago results</a></h4><ul><li>Spirit Airlines (NYSE:<a href='https://seekingalpha.com/symbol/SAVE' title='Spirit Airlines, Inc.'>SAVE</a>) <font color=\"red\">-3%</font> after-hours on disclosing <a href=\"https://www.sec.gov/Archives/edgar/data/1498710/000149871019000044/investorupdate071119.htm\" target=\"_blank\">updated Q2 guidance</a> that comes in below year-ago results based on two metrics.</li><li>The company expects top line revenue growth of nearly 19% for Q2 on a total revenue per ASM improvement of 5% Y/Y, but TRASM rose 8.9% in the prior-year quarter.</li><li>SAVE expects Q2 total cost per available seat mile excluding fuel to be in-line with initial guidance of a 4.6% Y/Y increase, but the company reported a 5.1% gain a year ago.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477305\" data-linked=\"Spirit Airlines guides two Q2 benchmarks below year-ago results\" data-tweet=\"$SAVE - Spirit Airlines guides two Q2 benchmarks below year-ago results https://seekingalpha.com/news/3477305-spirit-airlines-guides-two-q2-benchmarks-below-year-ago-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3477305-spirit-airlines-guides-two-q2-benchmarks-below-year-ago-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:27 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477298\" data-ts=\"1562880390\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477298-hook-ilmn-emkr-and-skyw-among-after-hour-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">HOOK, ILMN, EMKR and SKYW among after hour movers</a></h4><ul><li><strong>Gainers: </strong><a href='https://seekingalpha.com/symbol/HOOK' title='HOOKIPA Pharma Inc.'>HOOK</a> <font color=\"green\">+32.3%</font>. <a href='https://seekingalpha.com/symbol/SKYW' title='SkyWest, Inc.'>SKYW</a> <font color=\"green\">+5.0%</font>. <a href='https://seekingalpha.com/symbol/CBSH' title='Commerce Bancshares, Inc.'>CBSH</a> <font color=\"green\">+4.9%</font>. <a href='https://seekingalpha.com/symbol/FCPT' title='Four Corners Property Trust, Inc.'>FCPT</a> <font color=\"green\">+4.1%</font>. <a href='https://seekingalpha.com/symbol/FATE' title='Fate Therapeutics, Inc.'>FATE</a> <font color=\"green\">+3.7%</font>.</li><li><strong>Losers:</strong> <a href='https://seekingalpha.com/symbol/ILMN' title='Illumina, Inc.'>ILMN</a> <font color=\"red\">-15.8%</font>. <a href='https://seekingalpha.com/symbol/EMKR' title='EMCORE Corporation'>EMKR</a> <font color=\"red\">-14.9%</font>. <a href='https://seekingalpha.com/symbol/USX' title='U.S. Xpress Enterprises, Inc.'>USX</a> <font color=\"red\">-6.2%</font>. <a href='https://seekingalpha.com/symbol/TAL' title='TAL Education Group'>TAL</a> <font color=\"red\">-6.1%</font>. <a href='https://seekingalpha.com/symbol/IIPR' title='Innovative Industrial Properties, Inc.'>IIPR</a> <font color=\"red\">-5.7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477298\" data-linked=\"HOOK, ILMN, EMKR and SKYW among after hour movers\" data-tweet=\"$HOOK $SKYW $CBSH - HOOK, ILMN, EMKR and SKYW among after hour movers https://seekingalpha.com/news/3477298-hook-ilmn-emkr-and-skyw-among-after-hour-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3477298-hook-ilmn-emkr-and-skyw-among-after-hour-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477288\" data-ts=\"1562878828\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EMKR\" target=\"_blank\">EMKR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477288-emcoreminus-12-on-preliminary-q3-weakness\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">EMCORE -12% on preliminary Q3 weakness</a></h4><ul><li>EMCORE (NASDAQ:<a href='https://seekingalpha.com/symbol/EMKR' title='EMCORE Corporation'>EMKR</a>) shares <font color=\"red\">plummet 12.2%</font> to $2.89 after the company <a href=\"https://seekingalpha.com/pr/17569677-emcore-corporation-announces-preliminary-financial-results-third-fiscal-quarter-ended-june-30\" target=\"_blank\">cuts</a> its Q3 revenue outlook from $20M-22M to $17-17.5M.</li><li>The company attributes the weakness to the US-China trade tensions and softer MSO capital spend within the cable TV business.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477288\" data-linked=\"EMCORE -12% on preliminary Q3 weakness\" data-tweet=\"$EMKR - EMCORE -12% on preliminary Q3 weakness https://seekingalpha.com/news/3477288-emcoreminus-12-on-preliminary-q3-weakness?source=tweet\" data-url=\"https://seekingalpha.com/news/3477288-emcoreminus-12-on-preliminary-q3-weakness\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477285\" data-ts=\"1562878646\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BAM\" target=\"_blank\">BAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477285-brookfield-infrastructure-drops-3_3-after-equity-offering-announced\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Brookfield Infrastructure drops 3.3% after equity offering announced</a></h4><ul><li>Brookfield Infrastructure (NYSE:<a href='https://seekingalpha.com/symbol/BIP' title='Brookfield Infrastructure Partners L.P.'>BIP</a>) <font color=\"red\">slumps 3.3%</font> to $42.49 in after-hours trading after announcing a <a href=\"https://seekingalpha.com/pr/17569688-brookfield-infrastructure-announces-750034-900-equity-offering\" target=\"_blank\">11.8M-unit equity offering</a> priced at $42.50 per L.P. unit.</li><li>Brookfield Asset Management (NYSE:<a href='https://seekingalpha.com/symbol/BAM' title='Brookfield Asset Management Inc.'>BAM</a>) and certain of its related entities will buy, directly or indirectly, 6.128M redeemable partnership units of Brookfield Infrastructure's holding limited partnership units at the offering price concurrent with the offering.</li><li>Aggregate proceeds of the offering and the concurrent private placement will be $750M.</li><li>If the over-allotment option for up to an additional 1,764,750 L.P. units is exercised in full, the gross offering size will increase to $825M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477285\" data-linked=\"Brookfield Infrastructure drops 3.3% after equity offering announced\" data-tweet=\"$BAM $BIP $BIP - Brookfield Infrastructure drops 3.3% after equity offering announced https://seekingalpha.com/news/3477285-brookfield-infrastructure-drops-3_3-after-equity-offering-announced?source=tweet\" data-url=\"https://seekingalpha.com/news/3477285-brookfield-infrastructure-drops-3_3-after-equity-offering-announced\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:57 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>49&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477280\" data-ts=\"1562877977\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HOOK\" target=\"_blank\">HOOK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477280-hookipa-on-go-study-of-hbminus-201-in-hpv-cancers-shares-up-37-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Hookipa on go with study of HB-201 in HPV+ cancers; shares up 37% after hours</a></h4><ul><li>Thinly traded micro cap HOOKIPA Pharma (NASDAQ:<a href='https://seekingalpha.com/symbol/HOOK' title='HOOKIPA Pharma Inc.'>HOOK</a>) is up <font color=\"green\">37% </font>after hours on modestly higher volume in reaction to the FDA's <a href=\"https://seekingalpha.com/pr/17569592-hookipa-announces-fda-clearance-ind-application-hbminus-201-clinical-trial-treat-hpv-positive\" target=\"_blank\">sign-off</a> on its IND to start a Phase 1/2 clinical trial evaluating HB-201 for the potential treatment of HPV-positive cancers. The study should launch in H2 with preliminary data available in late 2020/early 2021.</li><li>The company says HB-201 is a <a href=\"https://www.hookipapharma.com/our-science/our-technologies/\" target=\"_blank\">TheraT</a>-based immunotherapy that expresses a non-oncogenic but highly antigenic E6/E7 fusion protein derived from HPV16, adding that it induced strong immune system responses (E6 and E7 antigen-specific CD8+ T cell response) in animal models. It believes that HB-201 has the potential to induce CD8+ T cell levels on par with adoptive cell therapies in an off-the-shelf approach.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477280\" data-linked=\"Hookipa on go with study of HB-201 in HPV+ cancers; shares up 37% after hours\" data-tweet=\"$HOOK - Hookipa on go with study of HB-201 in HPV+ cancers; shares up 37% after hours https://seekingalpha.com/news/3477280-hookipa-on-go-study-of-hbminus-201-in-hpv-cancers-shares-up-37-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3477280-hookipa-on-go-study-of-hbminus-201-in-hpv-cancers-shares-up-37-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477270\" data-ts=\"1562877136\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZM\" target=\"_blank\">ZM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477270-zoomplus-1_2-on-new-bull\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zoom +1.2% on new bull</a></h4><ul><li>Zoom Video Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/ZM' title='Zoom Video Communications, Inc.'>ZM</a>) gets an Overweight start at Stephens <a href=\"https://seekingalpha.com/news/3477263-stephens-comes-bullish-slack\" target=\"_blank\">alongside</a> a bullish call on Slack.</li><li>The firm assigns a $115 price target, implying a 26% upside.</li><li>ZM has a Hold average <a href=\"https://seekingalpha.com/symbol/ZM/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li><li>Zoom shares are <font color=\"green\">up 1.2%</font> after hours to $92.45.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477270\" data-linked=\"Zoom +1.2% on new bull\" data-tweet=\"$ZM - Zoom +1.2% on new bull https://seekingalpha.com/news/3477270-zoomplus-1_2-on-new-bull?source=tweet\" data-url=\"https://seekingalpha.com/news/3477270-zoomplus-1_2-on-new-bull\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477269\" data-ts=\"1562877088\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MNKD\" target=\"_blank\">MNKD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477269-mannkind-completes-manufacturing-buildout-shares-up-5-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MannKind completes manufacturing buildout; shares up 5% after hours</a></h4><ul><li>MannKind (NASDAQ:<a href='https://seekingalpha.com/symbol/MNKD' title='MannKind Corporation'>MNKD</a>) <a href=\"https://seekingalpha.com/pr/17569653-mannkind-expands-commercial-scale-manufacturing-capabilities-high-potency-molecules\" target=\"_blank\">announces</a> the completion of construction of a new high-potency manufacturing suite in its Danbury, CT facility.</li><li>The expansion will enable the company to produce dry powder formulations of ingredients such as epinephrine on a commercial scale.</li><li>Shares are up <font color=\"green\">5%</font> after hours.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477269\" data-linked=\"MannKind completes manufacturing buildout; shares up 5% after hours\" data-tweet=\"$MNKD - MannKind completes manufacturing buildout; shares up 5% after hours https://seekingalpha.com/news/3477269-mannkind-completes-manufacturing-buildout-shares-up-5-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3477269-mannkind-completes-manufacturing-buildout-shares-up-5-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477267\" data-ts=\"1562876899\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USX\" target=\"_blank\">USX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477267-u-s-xpressminus-3-after-cutting-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Xpress -3% after cutting guidance</a></h4><ul> <li>U.S. Xpress (NYSE:<a href='https://seekingalpha.com/symbol/USX' title='U.S. Xpress Enterprises, Inc.'>USX</a>) says now expects its Q2 adjusted operating ratio to be ~97.5% based off worse current market conditions. The ratio is higher than the 95.7% mark in Q1.</li> <li>In addition, the company is adjusting its full year 2019 adjusted operating ratio guidance to a range of 95.5% to 97.5%, where the high end would assume a continuation of the lackluster market conditions as seen in June through year end and compares to the previous adjusted operating ratio guidance of 93.0%.</li><li>The company says it's tightly managing costs and adjusting the net capital expenditure budget for 2019 to a range of $110M to $130M vs. $170M to $190M prior guidance. The net capital expenditure difference is expected to involve a combination of deferred tractor deliveries, and a reduction of the amount of planned replacement of leased equipment with owned. Overall tractor and trailer fleet age is not expected to change materially versus prior expectations.</li><li>USX <font color=\"green\">-3.33%</font> AH.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17569654-u-s-xpress-enterprises-updates-financial-guidance\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3477267\" data-linked=\"U.S. Xpress -3% after cutting guidance\" data-tweet=\"$USX - U.S. Xpress -3% after cutting guidance https://seekingalpha.com/news/3477267-u-s-xpressminus-3-after-cutting-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3477267-u-s-xpressminus-3-after-cutting-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:28 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477263\" data-ts=\"1562876669\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WORK\" target=\"_blank\">WORK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477263-stephens-comes-out-bullish-on-slack\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Stephens comes out bullish on Slack</a></h4><ul><li>Stephens starts Slack (NYSE:<a href='https://seekingalpha.com/symbol/WORK' title='Slack Technologies, Inc.'>WORK</a>) with an Overweight rating and a $43 price target, a 23% upside.</li><li>Recent news: Earlier today, Microsoft <a href=\"https://seekingalpha.com/news/3477238-microsoft-passes-slack-daus\" target=\"_blank\">revealed</a> its Teams has passed Slack in the number of daily active users.</li><li>Slack has an Outperform average <a href=\"https://seekingalpha.com/symbol/WORK/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li><li>WORK shares are <font color=\"green\">up 0.6%</font> after hours to $35.20.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477263\" data-linked=\"Stephens comes out bullish on Slack\" data-tweet=\"$WORK - Stephens comes out bullish on Slack https://seekingalpha.com/news/3477263-stephens-comes-out-bullish-on-slack?source=tweet\" data-url=\"https://seekingalpha.com/news/3477263-stephens-comes-out-bullish-on-slack\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>11&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477259\" data-ts=\"1562876527\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALK\" target=\"_blank\">ALK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477259-alaska-airplus-1-after-traffic-guidance-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Alaska Air +1% after traffic, guidance update</a></h4><ul> <li>Alaska Air Group (NYSE:<a href='https://seekingalpha.com/symbol/ALK' title='Alaska Air Group, Inc.'>ALK</a>) reports traffic rose 1.7% in June off a 1.9% rise in capacity.</li><li>The airline's load factor fell 10 bps to 88.2% during the month.</li><li>Alaska Air forecasts unit revenue will increase 5% in Q2 and costs per available seat mile will be 2.5% higher.</li><li>Shares of ALK are <font color=\"green\">up 1.0%</font> in AH trading.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17569589-alaska-air-group-reports-june-2019-operational-results\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3477259\" data-linked=\"Alaska Air +1% after traffic, guidance update\" data-tweet=\"$ALK - Alaska Air +1% after traffic, guidance update https://seekingalpha.com/news/3477259-alaska-airplus-1-after-traffic-guidance-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3477259-alaska-airplus-1-after-traffic-guidance-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477256\" data-ts=\"1562876227\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ILMN\" target=\"_blank\">ILMN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477256-illumina-down-15-after-hours-on-softer-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Illumina down 15% after hours on softer guidance</a></h4><ul><li>Illumina (NASDAQ:<a href='https://seekingalpha.com/symbol/ILMN' title='Illumina, Inc.'>ILMN</a>) slumps <font color=\"red\">15%</font> after hours in reaction to its <a href=\"https://seekingalpha.com/pr/17569603-illumina-reports-preliminary-revenue-second-quarter-fiscal-year-2019\" target=\"_blank\">preliminary Q2 revenue</a>, expected to be ~$835M, up less than 1% from a year ago ($830M) and below consensus of $888M. The less-than-expected growth was due to a large sequencing system order that failed to close, persistent weakness in the direct-to-consumer market and modest weakness in non-high-throughput systems.</li><li>As a result, management has lowered its 2019 revenue growth guidance to ~6% from 13 - 14%.</li><li>Sequencing revenue should grow ~10%, but its array business will be down ~14%. NovaSeq system shipments will be flat/slightly up from a year ago.</li><li>Its Q2 earnings call will be after the close on Monday, July 29.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477256\" data-linked=\"Illumina down 15% after hours on softer guidance\" data-tweet=\"$ILMN - Illumina down 15% after hours on softer guidance https://seekingalpha.com/news/3477256-illumina-down-15-after-hours-on-softer-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3477256-illumina-down-15-after-hours-on-softer-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:17 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477251\" data-ts=\"1562875567\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ACN\" target=\"_blank\">ACN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477251-accenture-appoints-sweet-ceo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Accenture appoints Sweet as CEO</a></h4><ul><li>Accenture (NYSE:<a href='https://seekingalpha.com/symbol/ACN' title='Accenture plc'>ACN</a>) names Julie Sweet as its next CEO, effective in September.</li><li>Sweet was heading the North American operations and takes the reins from interim CEO David Rowland, who will now become executive chairman.</li><li>Source: FT, citing an interview with Sweet.</li><li>ACN closed today <font color=\"green\">up 1.5%</font> to $194.67.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477251\" data-linked=\"Accenture appoints Sweet as CEO\" data-tweet=\"$ACN - Accenture appoints Sweet as CEO https://seekingalpha.com/news/3477251-accenture-appoints-sweet-ceo?source=tweet\" data-url=\"https://seekingalpha.com/news/3477251-accenture-appoints-sweet-ceo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477246\" data-ts=\"1562874757\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XEC\" target=\"_blank\">XEC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477246-cimarex-energy-cut-bmo-weak-prices-likely-to-remain-drag\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cimarex Energy cut at BMO as weak prices likely to remain a drag</a></h4><ul><li>Cimarex Energy (<a href='https://seekingalpha.com/symbol/XEC' title='Cimarex Energy Co.'>XEC</a> <font color='red'>-3.9%</font>) slumps after BMO Capital <a href=\"https://thefly.com/thestreet/realmoney/index.php/XECid2931518/XEC-Cimarex-Energy-downgraded-to-Market-Perform-from-Outperform-at-BMO-Capital\" target=\"_blank\">downgrades</a> shares to Market Perform from Outperform with a $67 price target, cut from $80, expecting weak prices for natural gas and natural gas liquids will remain a headwind to the company's earnings growth.</li><li>Analyst Phillip Jungwirth believes weak gas and NGL prices will pressure margins and XEC's ability to deliver \"sufficient growth within cash flow on a relative basis.\"</li><li>Jungwirth also notes BMO's 2019-20 oil production estimates come in 2%-7% below consensus estimates on 8%-10% higher capital spending.</li><li>XEC's average <a href=\"https://seekingalpha.com/symbol/XEC/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> is Outperform and its <a href=\"https://seekingalpha.com/symbol/XEC/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors' Rating</a> is Bullish, but its <a href=\"https://seekingalpha.com/symbol/XEC/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a> is Neutral.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477246\" data-linked=\"Cimarex Energy cut at BMO as weak prices likely to remain a drag\" data-tweet=\"$XEC - Cimarex Energy cut at BMO as weak prices likely to remain a drag https://seekingalpha.com/news/3477246-cimarex-energy-cut-bmo-weak-prices-likely-to-remain-drag?source=tweet\" data-url=\"https://seekingalpha.com/news/3477246-cimarex-energy-cut-bmo-weak-prices-likely-to-remain-drag\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477240\" data-ts=\"1562873892\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RLGY\" target=\"_blank\">RLGY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477240-realogyminus-1_9-barclays-slashes-price-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Realogy -1.9% as Barclays slashes price target</a></h4><ul><li>Realogy Holdings (NYSE:<a href='https://seekingalpha.com/symbol/RLGY' title='Realogy Holdings Corp.'>RLGY</a>) <font color=\"red\">slides 1.9%</font> after Barclays analyst Matthew Bouley cuts his price target on the stock to a Street-low of $5 from $9, noting that a lawsuit the company filed against Compass is a \"worrisome indicator.\"</li><li>Yesterday, Realogy<a href=\"https://www.wsj.com/articles/compass-engaged-in-illegal-activity-realogy-lawsuit-alleges-11562784434\" target=\"_blank\"> filed a lawsuit</a>, alleging that startup brokerage firm Compass stole its trade secrets and enticed agents into breaching noncompete agreements.</li><li>Writes that there's an increased probability that market share losses will persist for longer than expected.</li><li>Separately, JPMorgan analyst Anthony Paolone writes that the suit shows that Compass's recruiting efforts, and possibly others', continue to ramp up.</li><li>Sell-Side average rating of <a href=\"https://seekingalpha.com/symbol/RLGY/ratings/sell-side-ratings\" target=\"_blank\">Hold </a>(5 Hold, 2 Underperform, 1 Sell); average price target $8.75.</li><li>Realogy<a href=\"https://seekingalpha.com/symbol/RLGY/peers/comparison\" target=\"_blank\"> peers comparison</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477240\" data-linked=\"Realogy -1.9% as Barclays slashes price target\" data-tweet=\"$RLGY - Realogy -1.9% as Barclays slashes price target https://seekingalpha.com/news/3477240-realogyminus-1_9-barclays-slashes-price-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3477240-realogyminus-1_9-barclays-slashes-price-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:38 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477238\" data-ts=\"1562873355\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MSFT\" target=\"_blank\">MSFT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477238-microsoft-passes-slack-in-daus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microsoft passes Slack in DAUs</a></h4><ul><li>Microsoft (<a href='https://seekingalpha.com/symbol/MSFT' title='Microsoft Corporation'>MSFT</a>) Teams <a href=\"https://www.cnbc.com/2019/07/11/microsoft-teams-passes-slack-in-daily-users-rajesh-jha-explains-why.html\" target=\"_blank\">now has</a> over 13M DAUs compared to the 10M DAUs.</li><li>Slack (<a href='https://seekingalpha.com/symbol/WORK' title='Slack Technologies, Inc.'>WORK</a> <font color=\"red\">-0.5%</font>) had more than 10M DAUs in the three months ending on January 31.</li><li>Teams has 19M weekly active users. Slack no longer discloses the metric.</li><li>Teams is part of Microsoft's closely-watched Commercial Cloud segment, which grew revenues 41% in the most recent quarter.</li><li>Microsoft includes Teams in its Office 365 bundle at no extra charge, which has fueled the growth. Office 365 has 180M MAUs.</li><li>The tech giant is now adding new features, including read receipts and priority notifications.</li><li>Post updated with additional details.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477238\" data-linked=\"Microsoft passes Slack in DAUs\" data-tweet=\"$MSFT $MSFT $WORK - Microsoft passes Slack in DAUs https://seekingalpha.com/news/3477238-microsoft-passes-slack-in-daus?source=tweet\" data-url=\"https://seekingalpha.com/news/3477238-microsoft-passes-slack-in-daus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:29 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>35&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477237\" data-ts=\"1562872785\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BIB\" target=\"_blank\">BIB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477237-big-biopharma-in-red-investors-wait-for-trumps-drug-price-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Big Biopharma in the red as investors wait for Trump&#39;s drug price plan</a></h4><ul><li>Major drug makers are under water nearing the close as skittish investors move the sidelines ahead of President Trump's plan to peg Medicare reimbursement to the lowest ex-U.S. prices from a select group of countries.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/BIB' title='ProShares Ultra Nasdaq Biotechnology ETF'>BIB</a>, <a href='https://seekingalpha.com/symbol/GRX' title='The Gabelli Healthcare & Wellness Rx Trust'>GRX</a>, <a href='https://seekingalpha.com/symbol/THW' title='Tekla World Healthcare Fund'>THW</a>, <a href='https://seekingalpha.com/symbol/BME' title='BlackRock Health Sciences Trust'>BME</a>, <a href='https://seekingalpha.com/symbol/BIS' title='ProShares UltraShort Nasdaq Biotechnology ETF'>BIS</a>, <a href='https://seekingalpha.com/symbol/IXJ' title='iShares Global Healthcare ETF'>IXJ</a>, <a href='https://seekingalpha.com/symbol/ARKG' title='ARK Genomic Revolution Multi-Sector ETF'>ARKG</a>, <a href='https://seekingalpha.com/symbol/IDNA' title='iShares Genomics Immunology and Healthcare ETF'>IDNA</a>, <a href='https://seekingalpha.com/symbol/XLV' title='Health Care Select Sect SPDR ETF'>XLV</a>, <a href='https://seekingalpha.com/symbol/PJP' title='Invesco Dynamic Pharmaceuticals Portfolio ETF'>PJP</a>, <a href='https://seekingalpha.com/symbol/XBI' title='SPDR Biotech ETF'>XBI</a>, <a href='https://seekingalpha.com/symbol/IHE' title='iShares U.S. Pharmaceuticals ETF'>IHE</a>, <a href='https://seekingalpha.com/symbol/XPH' title='SPDR S&P Pharmaceuticals ETF'>XPH</a></li><li>Takeda (<a href='https://seekingalpha.com/symbol/TAK' title='Takeda Pharmaceutical Company Limited'>TAK</a> <font color=\"red\">-0.3%</font>), Bausch Health Companies (<a href='https://seekingalpha.com/symbol/BHC' title='Bausch Health Companies Inc.'>BHC</a> <font color=\"red\">-4.4%</font>), Roche (<a href='https://seekingalpha.com/symbol/RHHBY' title='Roche Holding AG'>OTCQX:RHHBY</a> <font color=\"red\">-1.9%</font>), AbbVie (<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a> <font color=\"red\">-1%</font>), Allergan (<a href='https://seekingalpha.com/symbol/AGN' title='Allergan plc'>AGN</a> <font color=\"red\">-0.3%</font>), AstraZeneca (<a href='https://seekingalpha.com/symbol/AZN' title='AstraZeneca PLC'>AZN</a> <font color=\"red\">-1.8%</font>), Bristol-Myers Squibb (<a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color=\"red\">-3.5%</font>), GlaxoSmithKline (<a href='https://seekingalpha.com/symbol/GSK' title='GlaxoSmithKline plc'>GSK</a> <font color=\"red\">-0.6%</font>), Johnson &amp; Johnson (<a href='https://seekingalpha.com/symbol/JNJ' title='Johnson & Johnson'>JNJ</a> <font color=\"red\">-1.1%</font>), Eli Lilly (<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a> <font color=\"red\">-4.4%</font>), Merck (<a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co., Inc.'>MRK</a> <font color=\"red\">-4.9%</font>), Novo Nordisk (<a href='https://seekingalpha.com/symbol/NVO' title='Novo Nordisk A/S'>NVO</a> <font color=\"red\">-3%</font>), Novartis (<a href='https://seekingalpha.com/symbol/NVS' title='Novartis AG'>NVS</a> <font color=\"red\">-1.5%</font>), Pfizer (<a href='https://seekingalpha.com/symbol/PFE' title='Pfizer Inc.'>PFE</a> <font color=\"red\">-2.7%</font>), Teva Pharmaceutical Industries (<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a> <font color=\"red\">-2.5%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3477237\" data-linked=\"Big Biopharma in the red as investors wait for Trump&#39;s drug price plan\" data-tweet=\"$BIB $GRX $THW - Big Biopharma in the red as investors wait for Trump&#39;s drug price plan https://seekingalpha.com/news/3477237-big-biopharma-in-red-investors-wait-for-trumps-drug-price-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/3477237-big-biopharma-in-red-investors-wait-for-trumps-drug-price-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:19 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>141&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477229\" data-ts=\"1562871511\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477229-microcaps-top-tech-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Microcaps top tech movers</a></h4><ul><li><strong>Gainers: </strong>Foresight Autonomous Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/FRSX' title='Foresight Autonomous Holdings Ltd.'>FRSX</a>) <font color=\"green\">+12%</font>. HC2 Holdings (NYSE:<a href='https://seekingalpha.com/symbol/HCHC' title='HC2 Holdings, Inc.'>HCHC</a>) <font color=\"green\">+8%</font>. StoneCo (NASDAQ:<a href='https://seekingalpha.com/symbol/STNE' title='StoneCo Ltd.'>STNE</a>) <font color=\"green\">+8%</font>. Gogo (NASDAQ:<a href='https://seekingalpha.com/symbol/GOGO' title='Gogo Inc.'>GOGO</a>) <font color=\"green\">+6%</font>. Powerbridge Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/PBTS' title='Powerbridge Technologies Co., Ltd.'>PBTS</a>) <font color=\"green\">+6%</font>.</li> <li><strong>Losers: </strong>Vislink Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/VISL' title='Vislink Technologies, Inc.'>VISL</a>) <font color=\"red\">-54%</font>. Moxian (NASDAQ:<a href='https://seekingalpha.com/symbol/MOXC' title='Moxian, Inc.'>MOXC</a>) <font color=\"red\">-14%</font>. Jiayin Group (NASDAQ:<a href='https://seekingalpha.com/symbol/JFIN' title='Jiayin Group Inc.'>JFIN</a>) <font color=\"red\">-14%</font>. Omnicell (NASDAQ:<a href='https://seekingalpha.com/symbol/OMCL' title='Omnicell, Inc.'>OMCL</a>) <font color=\"red\">-14%</font>. SemiLEDs Corporation (NASDAQ:<a href='https://seekingalpha.com/symbol/LEDS' title='SemiLEDs Corporation'>LEDS</a>) <font color=\"red\">-10%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3477229\" data-linked=\"Microcaps top tech movers\" data-tweet=\"$FRSX $HCHC $STNE - Microcaps top tech movers https://seekingalpha.com/news/3477229-microcaps-top-tech-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3477229-microcaps-top-tech-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477222\" data-ts=\"1562868711\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FAST\" target=\"_blank\">FAST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477222-fastenalminus-4-after-q1-earnings-miss-price-increaes-fail-to-offset-inflation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fastenal -4% after Q1 earnings miss, price increaes fail to offset inflation</a></h4><ul><li>Fastenal (<a href='https://seekingalpha.com/symbol/FAST' title='Fastenal Company'>FAST</a> <font color='red'>-4.2%</font>) tumbles to its lowest levels since January after missing <a href=\"https://seekingalpha.com/news/3477032-fastenal-eps-misses-0_01-misses-revenue\" target=\"_blank\">Q1 earnings</a> expectations even as revenues rose 8% Y/Y to $1.37B, driven by notable unit sales contributions from industrial vending and construction, as well as higher underlying market demand vs. the prior-year quarter.</li><li>FAST noted that it did see relative slowing in activity, as gross profit as a percentage of sales fell Y/Y to 46.9% from 48.7% and operating income slipped to 20.1% from 21.2% in the year-ago quarter.</li><li>\"While we successfully raised prices as one element of our strategy to offset tariffs placed to date on products sourced from China, those increases were not sufficient to also counter general inflation in the marketplace,\" the company said.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477222\" data-linked=\"Fastenal -4% after Q1 earnings miss, price increaes fail to offset inflation\" data-tweet=\"$FAST - Fastenal -4% after Q1 earnings miss, price increaes fail to offset inflation https://seekingalpha.com/news/3477222-fastenalminus-4-after-q1-earnings-miss-price-increaes-fail-to-offset-inflation?source=tweet\" data-url=\"https://seekingalpha.com/news/3477222-fastenalminus-4-after-q1-earnings-miss-price-increaes-fail-to-offset-inflation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477220\" data-ts=\"1562868148\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477220-quintana-energy-services-and-carbo-ceramics-among-energy-materials-gainers-camber-energy-and\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Quintana Energy Services and CARBO Ceramics among Energy/Materials gainers; Camber Energy and Platinum Group Metals among losers</a></h4><ul><li><b>Gainers: </b>Quintana Energy Services (NYSE:<a href='https://seekingalpha.com/symbol/QES' title='Quintana Energy Services Inc.'>QES</a>) <font color=\"green\">+9%</font>. CARBO Ceramics (NYSE:<a href='https://seekingalpha.com/symbol/CRR' title='CARBO Ceramics Inc.'>CRR</a>) <font color=\"green\">+8%</font>.</li><li><b>Losers: </b>Camber Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/CEI' title='Camber Energy, Inc.'>CEI</a>) <font color=\"red\">-16%</font>. Platinum Group Metals (NYSEMKT:<a href='https://seekingalpha.com/symbol/PLG' title='Platinum Group Metals Ltd.'>PLG</a>) <font color=\"red\">-7%</font>. Gold Fields (NYSE:<a href='https://seekingalpha.com/symbol/GFI' title='Gold Fields Limited'>GFI</a>) <font color=\"red\">-7%</font>. Coeur Mining (NYSE:<a href='https://seekingalpha.com/symbol/CDE' title='Coeur Mining, Inc.'>CDE</a>) <font color=\"red\">-7%</font>. Montage Resources (NYSE:<a href='https://seekingalpha.com/symbol/MR' title='Montage Resources Corporation'>MR</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477220\" data-linked=\"Quintana Energy Services and CARBO Ceramics among Energy/Materials gainers; Camber Energy and Platinum Group Metals among losers\" data-tweet=\"$QES $CRR $CEI - Quintana Energy Services and CARBO Ceramics among Energy/Materials gainers; Camber Energy and Platinum Group Metals among losers https://seekingalpha.com/news/3477220-quintana-energy-services-and-carbo-ceramics-among-energy-materials-gainers-camber-energy-and?source=tweet\" data-url=\"https://seekingalpha.com/news/3477220-quintana-energy-services-and-carbo-ceramics-among-energy-materials-gainers-camber-energy-and\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:02 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477219\" data-ts=\"1562868085\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/S\" target=\"_blank\">S</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477219-sprint-turns-on-mobile-5g-in-chicago\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sprint turns on mobile 5G in Chicago</a></h4><ul>   <li>Sprint (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color=\"red\">-3.2%</font>) has <a href=\"https://seekingalpha.com/pr/17569398-sprint-lights-true-mobile-5g-chicago\" target=\"_blank\">lit up its 5G network</a> in Chicago.</li>    <li>That marks the fifth of nine planned markets to first receive the company's True Mobile 5G. The service is now available in parts of Atlanta, Dallas-Fort Worth, Houston and Kansas City.</li>    <li>The Chicago addition will offer service to about 700,000 people; overall, the nine planned markets (to include Los Angeles, New York City, Phoenix and Washington, D.C.) will cover 2,100 square miles and 11M people total.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3477219\" data-linked=\"Sprint turns on mobile 5G in Chicago\" data-tweet=\"$S - Sprint turns on mobile 5G in Chicago https://seekingalpha.com/news/3477219-sprint-turns-on-mobile-5g-in-chicago?source=tweet\" data-url=\"https://seekingalpha.com/news/3477219-sprint-turns-on-mobile-5g-in-chicago\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>7&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477213\" data-ts=\"1562866366\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GRUB\" target=\"_blank\">GRUB</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477213-analysts-defend-grub-against-nypost-report\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts defend GRUB against NYPost report</a></h4><ul><li>Needham analyst Brad Erickson says the <a href=\"https://nypost.com/2019/07/10/state-liquor-authority-threatens-delivery-services-over-hefty-fees/\" target=\"_blank\"><em>New York Post</em></a> report weighing on GrubHub (<a href='https://seekingalpha.com/symbol/GRUB' title='Grubhub Inc.'>GRUB</a> <font color='red'>-3.6%</font>) shares seems \"thin to us.\"</li><li>Post sources say the New York State Liquor Authority wants to develop rules limiting the \"stiff fees\" charged by food delivery companies. The rules could cut GRUB's fee income to 10% of a takeout order, down from the current 15-30%.</li><li>Erickson notes that \"the Post seems to have it out for GRUB the past few months regarding their practices around phone orders.\"</li><li>The analyst sees \"a low probability of success here unless the entire third-party delivery industry is going to go through a similar regulatory curbing.\"</li><li>More action: Stephens analyst Will Slabaugh sees \"the risk of such a mandate as exceedingly low.\"</li><li>GRUB shares are <font color=\"red\">down 3.6%</font> to $74.27, paring some of the post-report losses.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477213\" data-linked=\"Analysts defend GRUB against NYPost report\" data-tweet=\"$GRUB - Analysts defend GRUB against NYPost report https://seekingalpha.com/news/3477213-analysts-defend-grub-against-nypost-report?source=tweet\" data-url=\"https://seekingalpha.com/news/3477213-analysts-defend-grub-against-nypost-report\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:32 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477206\" data-ts=\"1562864507\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477206-cemtrex-and-aar-corp-among-industrial-gainers-attis-industries-and-circor-among-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cemtrex and AAR Corp among Industrial gainers; Attis Industries and CIRCOR among losers</a></h4><ul><li><b>Gainers: </b>Cemtrex (NASDAQ:<a href='https://seekingalpha.com/symbol/CETX' title='Cemtrex, Inc.'>CETX</a>) <font color=\"green\">+12%</font>. AAR Corp (NYSE:<a href='https://seekingalpha.com/symbol/AIR' title='AAR Corp.'>AIR</a>) <font color=\"green\">+9%</font>.</li><li><b>Losers: </b>Attis Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/ATIS' title='Attis Industries, Inc.'>ATIS</a>) <font color=\"red\">-9%</font>. CIRCOR (NYSE:<a href='https://seekingalpha.com/symbol/CIR' title='CIRCOR International, Inc.'>CIR</a>) <font color=\"red\">-8%</font>. NF Energy Saving (NASDAQ:<a href='https://seekingalpha.com/symbol/BIMI' title='NF Energy Saving Corporation'>BIMI</a>) <font color=\"red\">-7%</font>. Zebra Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/ZBRA' title='Zebra Technologies Corporation'>ZBRA</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477206\" data-linked=\"Cemtrex and AAR Corp among Industrial gainers; Attis Industries and CIRCOR among losers\" data-tweet=\"$CETX $AIR $ATIS - Cemtrex and AAR Corp among Industrial gainers; Attis Industries and CIRCOR among losers https://seekingalpha.com/news/3477206-cemtrex-and-aar-corp-among-industrial-gainers-attis-industries-and-circor-among-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3477206-cemtrex-and-aar-corp-among-industrial-gainers-attis-industries-and-circor-among-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477204\" data-ts=\"1562864307\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477204-puyi-and-fednat-holding-financial-gainers-loop-industries-only-loser\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Puyi and FedNat Holding financial gainers, Loop Industries the only loser</a></h4><ul><li><b>Gainers:</b> Puyi (NASDAQ:<a href='https://seekingalpha.com/symbol/PUYI' title='Puyi Inc.'>PUYI</a>) <font color=\"green\">+8%</font>. FedNat Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/FNHC' title='FedNat Holding Company'>FNHC</a>) <font color=\"green\">+6%</font>.</li><li><b>Losers:</b> Loop Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/LOOP' title='Loop Industries, Inc.'>LOOP</a>) <font color=\"red\">-14%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477204\" data-linked=\"Puyi and FedNat Holding financial gainers, Loop Industries the only loser\" data-tweet=\"$PUYI $FNHC $LOOP - Puyi and FedNat Holding financial gainers, Loop Industries the only loser https://seekingalpha.com/news/3477204-puyi-and-fednat-holding-financial-gainers-loop-industries-only-loser?source=tweet\" data-url=\"https://seekingalpha.com/news/3477204-puyi-and-fednat-holding-financial-gainers-loop-industries-only-loser\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:58 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477198\" data-ts=\"1562862893\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477198-air-ci-and-omcl-among-midday-movers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AIR, CI and OMCL among midday movers</a></h4><ul><li><strong>Gainers: </strong>Immunic (NASDAQ:<a href='https://seekingalpha.com/symbol/IMUX' title='Immunic, Inc.'>IMUX</a>) <font color=\"green\">+48%</font>. Soliton (NASDAQ:<a href='https://seekingalpha.com/symbol/SOLY' title='Soliton, Inc.'>SOLY</a>) <font color=\"green\">+17%</font>. Biomerica (NASDAQ:<a href='https://seekingalpha.com/symbol/BMRA' title='Biomerica, Inc.'>BMRA</a>) <font color=\"green\">+14%</font>. Foresight Autonomous Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/FRSX' title='Foresight Autonomous Holdings Ltd.'>FRSX</a>) <font color=\"green\">+13%</font>. Cemtrex (NASDAQ:<a href='https://seekingalpha.com/symbol/CETX' title='Cemtrex, Inc.'>CETX</a>) <font color=\"green\">+12%</font>. Verastem (NASDAQ:<a href='https://seekingalpha.com/symbol/VSTM' title='Verastem, Inc.'>VSTM</a>) <font color=\"green\">+11%</font>. Cigna Corporation (NYSE:<a href='https://seekingalpha.com/symbol/CI' title='Cigna Corporation'>CI</a>) <font color=\"green\">+11%</font>. Mastech Digital (NYSEMKT:<a href='https://seekingalpha.com/symbol/MHH' title='Mastech Digital, Inc.'>MHH</a>) <font color=\"green\">+10%</font>. AquaVenture Holdings (NYSE:<a href='https://seekingalpha.com/symbol/WAAS' title='AquaVenture Holdings Limited'>WAAS</a>) <font color=\"green\">+10%</font>. AAR Corp. (NYSE:<a href='https://seekingalpha.com/symbol/AIR' title='AAR Corp.'>AIR</a>) <font color=\"green\">+9%</font>.</li> <li><strong>Losers: </strong>Vislink Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/VISL' title='Vislink Technologies, Inc.'>VISL</a>) <font color=\"red\">-54%</font>. Oasmia Pharmaceutical (NASDAQ:<a href='https://seekingalpha.com/symbol/OASM' title='Oasmia Pharmaceutical AB &#40;publ&#41;'>OASM</a>) <font color=\"red\">-21%</font>. Valeritas Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/VLRX' title='Valeritas Holdings, Inc.'>VLRX</a>) <font color=\"red\">-17%</font>. Loop Industries (NASDAQ:<a href='https://seekingalpha.com/symbol/LOOP' title='Loop Industries, Inc.'>LOOP</a>) <font color=\"red\">-16%</font>. Moxian (NASDAQ:<a href='https://seekingalpha.com/symbol/MOXC' title='Moxian, Inc.'>MOXC</a>) <font color=\"red\">-16%</font>. Tarena International (NASDAQ:<a href='https://seekingalpha.com/symbol/TEDU' title='Tarena International, Inc.'>TEDU</a>) <font color=\"red\">-13%</font>. Omnicell (NASDAQ:<a href='https://seekingalpha.com/symbol/OMCL' title='Omnicell, Inc.'>OMCL</a>) <font color=\"red\">-12%</font>. SenesTech (NASDAQ:<a href='https://seekingalpha.com/symbol/SNES' title='SenesTech, Inc.'>SNES</a>) <font color=\"red\">-12%</font>. iFresh (NASDAQ:<a href='https://seekingalpha.com/symbol/IFMK' title='iFresh Inc.'>IFMK</a>) <font color=\"red\">-13%</font>. Camber Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/CEI' title='Camber Energy, Inc.'>CEI</a>) <font color=\"red\">-12%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3477198\" data-linked=\"AIR, CI and OMCL among midday movers\" data-tweet=\"$IMUX $SOLY $BMRA - AIR, CI and OMCL among midday movers https://seekingalpha.com/news/3477198-air-ci-and-omcl-among-midday-movers?source=tweet\" data-url=\"https://seekingalpha.com/news/3477198-air-ci-and-omcl-among-midday-movers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477196\" data-ts=\"1562862271\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAKSF\" target=\"_blank\">MAKSF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477196-fashion-shakeup-marks-spencer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fashion shakeup at Marks &amp; Spencer</a></h4><ul> <li>Marks &amp; Spencer (<a href='https://seekingalpha.com/symbol/MAKSF' title='Marks and Spencer Group plc'>OTCQX:MAKSF</a>) <a href=\"https://www.bbc.com/news/business-48956183\" target=\"_blank\">fires</a> well-known fashion boss Jill McDonald as part of an effort to address long-standing issues in the company's clothing and home supply chain around availability and flow of product.</li> <li>CEO Steve Rowe is taking over for McDonald in the near term. Rowe has been very vocal about some of the mistakes that M&amp;S has made in clothing recently.</li> <li>Shares of Marks &amp; Spence <font color=\"red\">fell 1%</font> in London today.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3477196\" data-linked=\"Fashion shakeup at Marks &amp; Spencer\" data-tweet=\"$MAKSF - Fashion shakeup at Marks &amp; Spencer https://seekingalpha.com/news/3477196-fashion-shakeup-marks-spencer?source=tweet\" data-url=\"https://seekingalpha.com/news/3477196-fashion-shakeup-marks-spencer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:24 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477193\" data-ts=\"1562861673\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ALL\" target=\"_blank\">ALL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477193-allstateminus-1_6-after-bearish-note-credit-suisse\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Allstate -1.6% after bearish note by Credit Suisse</a></h4><ul><li>Allstate (NYSE:<a href='https://seekingalpha.com/symbol/ALL' title='The Allstate Corporation'>ALL</a>) <font color=\"red\">falls 1.6% </font>after Credit Suisse <a href=\"https://www.marketbeat.com/ratings/USA/latest/\" target=\"_blank\">downgrades </a>the insurer to underperform from neutral.</li><li>During the past six months, Allstate <a href=\"https://seekingalpha.com/symbol/ALL/momentum/performance\" target=\"_blank\">has risen 25%</a>, exceeding the financial sector's median performance of +4.9%.</li><li>Quant rating<a href=\"https://seekingalpha.com/symbol/ALL/ratings/quant-ratings\" target=\"_blank\"> Neutral</a>; Sell-Side average rating <a href=\"https://seekingalpha.com/symbol/ALL/ratings/sell-side-ratings\" target=\"_blank\">Outperform </a>(6 Buy, 3 Outperform, 8 Hold, 2 Underperform).</li></ul><div class=\"tiny-share-widget\" data-id=\"3477193\" data-linked=\"Allstate -1.6% after bearish note by Credit Suisse\" data-tweet=\"$ALL - Allstate -1.6% after bearish note by Credit Suisse https://seekingalpha.com/news/3477193-allstateminus-1_6-after-bearish-note-credit-suisse?source=tweet\" data-url=\"https://seekingalpha.com/news/3477193-allstateminus-1_6-after-bearish-note-credit-suisse\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:14 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477191\" data-ts=\"1562860962\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477191-sportsmans-warehouse-and-xcel-brands-among-consumer-gainers-davidstea-and-tenneco-among\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sportsman&#39;s Warehouse and Xcel Brands among Consumer gainers; DAVIDsTEA and\nTenneco among losers</a></h4><ul><li><b>Gainers: </b>Sportsman's Warehouse (NASDAQ:<a href='https://seekingalpha.com/symbol/SPWH' title='Sportsman&#39;s Warehouse Holdings, Inc.'>SPWH</a>) <font color=\"green\">+8%</font>. Xcel Brands (NASDAQ:<a href='https://seekingalpha.com/symbol/XELB' title='Xcel Brands, Inc.'>XELB</a>) <font color=\"green\">+5%</font>.</li><li><b>Losers: </b>DAVIDsTEA (NASDAQ:<a href='https://seekingalpha.com/symbol/DTEA' title='DAVIDsTEA Inc.'>DTEA</a>) <font color=\"red\">-9%</font>. Tenneco (NYSE:<a href='https://seekingalpha.com/symbol/TEN' title='Tenneco Inc.'>TEN</a>) <font color=\"red\">-8%</font>. Superior Industries (NYSE:<a href='https://seekingalpha.com/symbol/SUP' title='Superior Industries International, Inc.'>SUP</a>) <font color=\"red\">-8%</font>. Dean Foods (NYSE:<a href='https://seekingalpha.com/symbol/DF' title='Dean Foods Company'>DF</a>) <font color=\"red\">-8%</font>. NIO (NYSE:<a href='https://seekingalpha.com/symbol/NIO' title='NIO Inc.'>NIO</a>) <font color=\"red\">-6%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477191\" data-linked=\"Sportsman&#39;s Warehouse and Xcel Brands among Consumer gainers; DAVIDsTEA and\nTenneco among losers\" data-tweet=\"$SPWH $XELB $DTEA - Sportsman&#39;s Warehouse and Xcel Brands among Consumer gainers; DAVIDsTEA andTenneco among losers https://seekingalpha.com/news/3477191-sportsmans-warehouse-and-xcel-brands-among-consumer-gainers-davidstea-and-tenneco-among?source=tweet\" data-url=\"https://seekingalpha.com/news/3477191-sportsmans-warehouse-and-xcel-brands-among-consumer-gainers-davidstea-and-tenneco-among\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477188\" data-ts=\"1562860664\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CXW\" target=\"_blank\">CXW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477188-geo-corecivic-get-letters-from-house-oversight-committee\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GEO, CoreCivic get letters from House Oversight Committee</a></h4><ul><li>With the conditions at immigration detention centers in the news, GEO Group (<a href='https://seekingalpha.com/symbol/GEO' title='The GEO Group, Inc.'>GEO</a> <font color='red'>-2.9%</font>) and CoreCivic (<a href='https://seekingalpha.com/symbol/CXW' title='CoreCivic, Inc.'>CXW</a> <font color='red'>-3.6%</font>) <a href=\"https://oversight.house.gov/news/press-releases/oversight-committee-investigates-for-profit-immigrant-detention-center\" target=\"_blank\">get letters </a>from the House Committee on Oversight and Reform expressing concern that the value of contracts they've received have increased \"significantly under the Trump administration and resulted in massive profits.\"</li><li>Rep. Elijah E. Cummings, chairman of the Committee on Oversight and Reform, and Rep. Jamie Raskin, chairman of the subcommittee on Civil Rights and Civil Liberties, sent letters to those two companies, plus privately held DC Capital Partners, which owns Comprehensive Health Services that runs the country's largest shelter for immigrant children.</li><li>The letters note that GEO received $300M in new ICE contract awards in FY2017, up more than $100M from the prior year, and rose to almost $342M in FY2018.</li><li>CoreCivic received ~$135M in new ICE contracts in FY2017, up $36M Y/Y, and almost $141M in FY2018.</li><li>Both CoreCivic and GEO have said they don't operate facilities that house unaccompanied minors.</li><li>The House committee is investigating the Trump Administration's increasing use of for-profit contractors to detain immigrants, \"including a troubling series of reports of health and safety violations.\"</li></ul><div class=\"tiny-share-widget\" data-id=\"3477188\" data-linked=\"GEO, CoreCivic get letters from House Oversight Committee\" data-tweet=\"$CXW $GEO $GEO - GEO, CoreCivic get letters from House Oversight Committee https://seekingalpha.com/news/3477188-geo-corecivic-get-letters-from-house-oversight-committee?source=tweet\" data-url=\"https://seekingalpha.com/news/3477188-geo-corecivic-get-letters-from-house-oversight-committee\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>36&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477178\" data-ts=\"1562859112\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477178-voxx-internationalplus-3_4-post-q1-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VOXX International +3.4% post Q1 results</a></h4><ul><li>VOXX International (<a href='https://seekingalpha.com/symbol/VOXX' title='VOXX International Corporation'>VOXX</a> <font color=\"green\">+3.4%</font>) reported <a href=\"https://seekingalpha.com/pr/17568282-voxx-international-corporation-reports-fiscal-2020-first-quarter-financial-results\" target=\"_blank\">Q1</a> revenue decrease of 7.3% Y/Y to $93.5M.</li><li>Segment revenues: Automotive Electronics of $29.6M (-25.3% Y/Y); Consumer Electronics of $63.7M (+4.6% Y/Y) &amp; Biometrics essentially had no net sales for Q1.</li><li>Q1 Overall gross margin: Total gross <font color=\"green\">increased 40 bps</font> to 27.8%; Automotive Electronics <font color=\"red\">declined 280 bps</font> to 22.4%; Consumer Electronics <font color=\"green\">increased 130 bps</font> to 30% &amp; Biometrics segment margin of 1,816.7% as compared to 61.8% Y/Y.</li><li>Adj. EBITDA margin also <font color=\"red\">declined 63 bps</font> to 0.86%.</li><li>Cash and equivalents of $60M, an increase of $1.8M Q/Q; Total debt as of May 31, 2019 was $16M &amp; Total long-term debt was $7.5M.</li><li>The Company anticipates its net cash position will increase up to ~$31 M, pending the successful sale of VOXX German Accessory Holdings and its real estate holding in Pulheim, Germany.</li><li>Company to begin executing its share repurchase program for the repurchase of up to3M shares.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3476980-voxx-international-reports-q1-results\" target=\"_blank\">VOXX International reports Q1 results</a> (Jul. 10 2019)</li></ul><div class=\"tiny-share-widget\" data-id=\"3477178\" data-linked=\"VOXX International +3.4% post Q1 results\" data-tweet=\"$VOXX - VOXX International +3.4% post Q1 results https://seekingalpha.com/news/3477178-voxx-internationalplus-3_4-post-q1-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3477178-voxx-internationalplus-3_4-post-q1-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:31 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477171\" data-ts=\"1562858470\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477171-healthcare-top-5-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers</a></h4><ul><li><b>Gainers:</b> Immunic (NASDAQ:<a href='https://seekingalpha.com/symbol/IMUX' title='Immunic, Inc.'>IMUX</a>) <font color=\"green\">+48%</font>. Soliton (NASDAQ:<a href='https://seekingalpha.com/symbol/SOLY' title='Soliton, Inc.'>SOLY</a>) <font color=\"green\">+20%</font>. Cigna (NYSE:<a href='https://seekingalpha.com/symbol/CI' title='Cigna Corporation'>CI</a>) <font color=\"green\">+12%</font>. Biomerica (NASDAQ:<a href='https://seekingalpha.com/symbol/BMRA' title='Biomerica, Inc.'>BMRA</a>) <font color=\"green\">+11%</font>. Trinity Biotech (NASDAQ:<a href='https://seekingalpha.com/symbol/TRIB' title='Trinity Biotech plc'>TRIB</a>) <font color=\"green\">+9%</font>.</li><li><b>Losers:</b> Valeritas Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/VLRX' title='Valeritas Holdings, Inc.'>VLRX</a>) <font color=\"red\">-18%</font>. Eyenovia (NASDAQ:<a href='https://seekingalpha.com/symbol/EYEN' title='Eyenovia, Inc.'>EYEN</a>) <font color=\"red\">-13%</font>. Leap Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/LPTX' title='Leap Therapeutics, Inc.'>LPTX</a>) <font color=\"red\">-12%</font>. Oasmia Pharmaceutical (NASDAQ:<a href='https://seekingalpha.com/symbol/OASM' title='Oasmia Pharmaceutical AB &#40;publ&#41;'>OASM</a>) <font color=\"red\">-12%</font>. Tonix Pharmaceuticals Holding (NASDAQ:<a href='https://seekingalpha.com/symbol/TNXP' title='Tonix Pharmaceuticals Holding Corp.'>TNXP</a>) <font color=\"red\">-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477171\" data-linked=\"Healthcare - Top 5 Gainers / Losers\" data-tweet=\"$IMUX $SOLY $CI - Healthcare - Top 5 Gainers / Losers https://seekingalpha.com/news/3477171-healthcare-top-5-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3477171-healthcare-top-5-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477307\" data-ts=\"1562858277\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPN\" target=\"_blank\">SPN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477307-superior-energy-cut-susquehanna-on-balance-sheet-challenges\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Superior Energy cut at Susquehanna on balance sheet challenges</a></h4><ul><li>Superior Energy Services (<a href='https://seekingalpha.com/symbol/SPN' title='Superior Energy Services, Inc.'>SPN</a> <font color='red'>-5.7%</font>) sinks to within pennies of its 52-week low as Susquehanna analyst Charles Minervino <a href=\"https://thefly.com/thestreet/realmoney/index.php/SPN;SLB;HP;HAL;PTENid2931068/SPN;SLB;HP;HAL;PTEN-Superior-Energy-downgraded-at-Susquehanna-on-balance-sheet-challenges\" target=\"_blank\">downgrades</a> shares to Neutral from Positive and slashes his price target to just $1.50 from $7.</li><li>Minervino says he needs to see better clarity on a resolution to SPN's $1.3B of debt overhang, and he recommends weighting toward large-cap, generally more diversified energy services stocks such as Schlumberger, Halliburton, Helmerich &amp; Payne and Patterson-UTI.</li><li>SPN's average <a href=\"https://seekingalpha.com/symbol/SPN/ratings/sell-side-ratings\" target=\"_blank\">Sell Side Rating</a> is Hold, but its <a href=\"https://seekingalpha.com/symbol/SPN/ratings/author-ratings#filter=all\" target=\"_blank\">Seeking Alpha Authors' Rating</a> is Bearish and its <a href=\"https://seekingalpha.com/symbol/SPN/ratings/quant-ratings\" target=\"_blank\">Quant Rating</a> is Very Bearish.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477307\" data-linked=\"Superior Energy cut at Susquehanna on balance sheet challenges\" data-tweet=\"$SPN - Superior Energy cut at Susquehanna on balance sheet challenges https://seekingalpha.com/news/3477307-superior-energy-cut-susquehanna-on-balance-sheet-challenges?source=tweet\" data-url=\"https://seekingalpha.com/news/3477307-superior-energy-cut-susquehanna-on-balance-sheet-challenges\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477170\" data-ts=\"1562857939\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477170-t-mobile-sprint-slide-on-report-merger-slowed\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">T-Mobile, Sprint slide on report merger has slowed</a></h4><ul>   <li>T-Mobile (<a href=\"http://seekingalpha.com/symbol/TMUS\" target=\"_blank\">TMUS</a> <font color=\"red\">-1.9%</font>) and Sprint (<a href=\"http://seekingalpha.com/symbol/S\" target=\"_blank\">S</a> <font color=\"red\">-3.6%</font>) are sliding off a new <i>Wall Street Journal</i> report that <a href=\"https://www.wsj.com/articles/t-mobile-sprint-talks-slow-over-dish-ownership-11562857383\" target=\"_blank\">merger talks have slowed</a>, over conditions around the involvement of Dish Network (<a href=\"http://seekingalpha.com/symbol/DISH\" target=\"_blank\">DISH</a> <font color=\"green\">+0.5%</font>) in the deal.</li>    <li>Talks are ongoing, but the two wireless carriers are planning to extend their merger agreement beyond its July 29 deadline to buy more time, according to the report -- a second extension of a deal that has dragged out more than a year.</li>    <li>Dish emerged as a favorite to acquire divested assets and in time develop a fourth rival to the combined company, Verizon (<a href=\"http://seekingalpha.com/symbol/VZ\" target=\"_blank\">VZ</a> <font color=\"red\">-0.1%</font>) and AT&amp;T (<a href=\"http://seekingalpha.com/symbol/T\" target=\"_blank\">T</a> <font color=\"red\">-0.4%</font>). But a bone of contention rests on who could later buy into the Dish network, with T-Mobile parent Deutsche Telekom (<a href=\"http://seekingalpha.com/symbol/DTEGY\" target=\"_blank\">DTEGY</a> <font color=\"red\">-0.5%</font>) pushing for 5% limits on investors.</li>    <li>There's also discussion about how much traffic Dish could send over the new T-Mobile's network in the meantime.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3477170\" data-linked=\"T-Mobile, Sprint slide on report merger has slowed\" data-tweet=\"$TMUS $S $DISH - T-Mobile, Sprint slide on report merger has slowed https://seekingalpha.com/news/3477170-t-mobile-sprint-slide-on-report-merger-slowed?source=tweet\" data-url=\"https://seekingalpha.com/news/3477170-t-mobile-sprint-slide-on-report-merger-slowed\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:12 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>65&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477169\" data-ts=\"1562857692\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/Z\" target=\"_blank\">Z</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477169-zillowminus-4-on-redfin-opendoor-tie-up\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zillow -4% on Redfin-Opendoor tie-up</a></h4><ul><li>Opendoor and Redfin (<a href='https://seekingalpha.com/symbol/RDFN' title='Redfin Corporation'>RDFN</a> <font color='green'>+0.2%</font>) <a href=\"https://seekingalpha.com/pr/17568958-opendoor-redfin-partner-provide-options-home-sellers\" target=\"_blank\">team up</a> so that home sellers in Atlanta and Phoenix can request an Opendoor offer through RDFN's site and app.</li><li>Redfin will also keep expanding its RedfinNow instant offer service.</li><li>Zillow (NASDAQ:<a href='https://seekingalpha.com/symbol/Z' title='Zillow Group, Inc.'>Z</a>) shares <font color=\"red\">slide 4.2%</font> to $49.20. The company has the competing Offers product.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477169\" data-linked=\"Zillow -4% on Redfin-Opendoor tie-up\" data-tweet=\"$Z $RDFN $Z - Zillow -4% on Redfin-Opendoor tie-up https://seekingalpha.com/news/3477169-zillowminus-4-on-redfin-opendoor-tie-up?source=tweet\" data-url=\"https://seekingalpha.com/news/3477169-zillowminus-4-on-redfin-opendoor-tie-up\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>50&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477159\" data-ts=\"1562856512\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NOVN\" target=\"_blank\">NOVN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477159-novan-up-3-on-advancement-of-sb206\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novan up 3% on advancement of SB206</a></h4><ul><li>Novan (<a href='https://seekingalpha.com/symbol/NOVN' title='Novan, Inc.'>NOVN</a> <font color=\"green\">+2.5%</font>) perks up, albeit on light volume, following its <a href=\"https://seekingalpha.com/pr/17568771-novan-sb206-phase-3-molluscum-pivotal-program-update\" target=\"_blank\">announcement </a>that its Phase 3 studies (B-SIMPLE 1&amp;2) evaluating <a href=\"http://www.novan.com/pipeline/sb206/\" target=\"_blank\">SB206 </a>for the treatment of molluscum contagiosum are more than 50% enrolled.</li><li>Topline data should be available in Q1 2020.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477159\" data-linked=\"Novan up 3% on advancement of SB206\" data-tweet=\"$NOVN - Novan up 3% on advancement of SB206 https://seekingalpha.com/news/3477159-novan-up-3-on-advancement-of-sb206?source=tweet\" data-url=\"https://seekingalpha.com/news/3477159-novan-up-3-on-advancement-of-sb206\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:48 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477156\" data-ts=\"1562856085\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477156-natural-gas-inventory-build-tops-estimates\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Natural gas inventory build tops estimates</a></h4><ul><li><a href=\"http://ir.eia.gov/ngs/ngs.html\" target=\"_blank\">EIA Natural Gas Inventory:</a> <strong>+81 Bcf</strong> vs. +73 Bcf consensus, +89 Bcf last week.</li><li>Futures <font color=\"green\">+1.35%</font> to $2.477.</li><li>ETFs:<a href='https://seekingalpha.com/symbol/UNG' title='The United States Natural Gas ETF, LP'>UNG</a>, <a href='https://seekingalpha.com/symbol/DGAZ' title='VelocityShares 3x Inverse Natural Gas ETN'>DGAZ</a>, <a href='https://seekingalpha.com/symbol/UGAZ' title='VelocityShares 3x Long Natural Gas ETN'>UGAZ</a>, <a href='https://seekingalpha.com/symbol/BOIL' title='ProShares Ultra Bloomberg Natural Gas ETF'>BOIL</a>, <a href='https://seekingalpha.com/symbol/KOLD' title='ProShares UltraShort Bloomberg Natural Gas ETF'>KOLD</a>, <a href='https://seekingalpha.com/symbol/UNL' title='The United States 12 Month Natural Gas ETF, LP'>UNL</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3477156\" data-linked=\"Natural gas inventory build tops estimates\" data-tweet=\"$UNG $DGAZ $UGAZ - Natural gas inventory build tops estimates https://seekingalpha.com/news/3477156-natural-gas-inventory-build-tops-estimates?source=tweet\" data-url=\"https://seekingalpha.com/news/3477156-natural-gas-inventory-build-tops-estimates\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>52&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477155\" data-ts=\"1562855831\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KAR\" target=\"_blank\">KAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477155-divided-sentiment-on-kar-auction-services\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Divided sentiment on KAR Auction Services</a></h4><ul> <li>KAR Auction Services (NYSE:<a href='https://seekingalpha.com/symbol/KAR' title='KAR Auction Services, Inc.'>KAR</a>) is on watch after Off Wall Street <a href=\"https://www.streetinsider.com/Analyst+Comments/Kar+Auction+Services+%28KAR%29+Initiated+as+Short+at+Off+Wall+Street/15694147.html\" target=\"_blank\">reportedly</a> issues a short recommendation on the auction services provider.</li> <li>KAR is seen by the research firm as potentially losing market share.</li> <li>The Seeking Alpha Quant Rating is already flashing <a href=\"https://seekingalpha.com/symbol/KAR/ratings/quant-ratings\" target=\"_blank\">Very Bearish</a> on KAR, but the sell-side consensus still stands at Outperform.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3477155\" data-linked=\"Divided sentiment on KAR Auction Services\" data-tweet=\"$KAR - Divided sentiment on KAR Auction Services https://seekingalpha.com/news/3477155-divided-sentiment-on-kar-auction-services?source=tweet\" data-url=\"https://seekingalpha.com/news/3477155-divided-sentiment-on-kar-auction-services\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477154\" data-ts=\"1562855703\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WAAS\" target=\"_blank\">WAAS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477154-aquaventure-announces-pricing-of-public-offering\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AquaVenture announces pricing of public offering</a></h4><ul><li>AquaVenture Holdings (<a href='https://seekingalpha.com/symbol/WAAS' title='AquaVenture Holdings Limited'>WAAS</a> <font color='green'>+7.3%</font>) <a href=\"https://seekingalpha.com/pr/17568380-aquaventure-announces-pricing-public-offering-ordinary-shares\" target=\"_blank\">announced the pricing</a> of its offering of 4.1M ordinary shares at a public offering price of $16.88/share.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3476328-aquaventure-slips-2-percent-follow-offering\" target=\"_blank\">AquaVenture slips ~2% after follow-on offering</a> (July 8).</li></ul><div class=\"tiny-share-widget\" data-id=\"3477154\" data-linked=\"AquaVenture announces pricing of public offering\" data-tweet=\"$WAAS - AquaVenture announces pricing of public offering https://seekingalpha.com/news/3477154-aquaventure-announces-pricing-of-public-offering?source=tweet\" data-url=\"https://seekingalpha.com/news/3477154-aquaventure-announces-pricing-of-public-offering\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:35 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477139\" data-ts=\"1562855461\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AIMT\" target=\"_blank\">AIMT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477139-aimmune-down-7-on-cautious-icer-report-on-peanut-allergy-treatments\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aimmune down 7% on cautious ICER report on peanut allergy treatments</a></h4><ul><li>Aimmune Therapeutics (<a href='https://seekingalpha.com/symbol/AIMT' title='Aimmune Therapeutics, Inc.'>AIMT</a> <font color=\"red\">-6.5%</font>) is down on below-average volume on the heels of a <a href=\"https://icer-review.org/announcements/final_report_peanut_allergy/\" target=\"_blank\">cautionary report</a> on peanut allergy treatments by the non-profit <a href=\"https://icer-review.org/\" target=\"_blank\">Institute for Clinical and Economic Review</a> &#40;ICER&#41;.</li><li>The report examined the clinical effectiveness of AR101 and DBV Technologies' (<a href='https://seekingalpha.com/symbol/DBVT' title='DBV Technologies S.A.'>DBVT</a> <font color=\"green\">+0.8%</font>) Viaskin Peanut. Neither are approved for sale in the U.S. but could be in 2020.</li><li>ICER cites several concerns: the need for indefinite treatment without supporting evidence of long-term safety and effectiveness, the persistence of risk of allergic reactions from inadvertent peanut exposure despite desensitization and the \"burdensome\" increase in epinephrine use in the one-year studies conducted by both companies.</li><li>On the economic front, ICER calculated that the fair value-based price benchmark range for AR101 would be $4,800-7,200 per year compared to $3,000 - 4,500 per year for Viaskin Peanut, meaning that, conceptually, AR101 would deliver more value. The actual long-term value for the money for either therapy is unknown at this point since commercial pricing has not been set.</li><li>ICER has issued an Affordability and Access Alert to stakeholders and policy makers that the added costs of the treatments may be difficult for the U.S. health system to absorb in the near term without displacing other essential services.</li><li>Unsurprisingly, Aimmune <a href=\"https://seekingalpha.com/pr/17568704-aimmune-statement-institute-clinical-economic-review-icer-final-report-ar101-peanut-allergy\" target=\"_blank\">takes issue</a> with the report saying ICER failed to consider available long-term outcomes data or improvements in patients' quality-of-life as shown in its ARTEMIS and PALISADE studies of AR101.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477139\" data-linked=\"Aimmune down 7% on cautious ICER report on peanut allergy treatments\" data-tweet=\"$AIMT $DBVT - Aimmune down 7% on cautious ICER report on peanut allergy treatments https://seekingalpha.com/news/3477139-aimmune-down-7-on-cautious-icer-report-on-peanut-allergy-treatments?source=tweet\" data-url=\"https://seekingalpha.com/news/3477139-aimmune-down-7-on-cautious-icer-report-on-peanut-allergy-treatments\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:31 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>42&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477149\" data-ts=\"1562855184\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NTNX\" target=\"_blank\">NTNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477149-nutanixplus-6_5-bull-sees-upswing\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nutanix +6.5% as bull sees upswing</a></h4><ul><li>Nutanix (NASDAQ:<a href='https://seekingalpha.com/symbol/NTNX' title='Nutanix, Inc.'>NTNX</a>) is showing \"early signs of an upswing\" after the recent rout, according to William Blair.</li><li>Blair analyst Jason Ader maintains an Outperform rating and says VAR commentary suggests a July quarter business pickup as NTNX pulled in more seven-figure deals.</li><li>The analyst cites anecdotal evidence that NTNX has refocused its HCI business, emphasizing footprint gains over \"jamming its full-stack vision down customers\u2019 throats.\"</li><li>Nutanix shares are <font color=\"green\">up 6.5%</font> to $27.56.</li><li>NTNX has an Outperform <a href=\"https://seekingalpha.com/symbol/NTNX/ratings/sell-side-ratings\" target=\"_blank\">average Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477149\" data-linked=\"Nutanix +6.5% as bull sees upswing\" data-tweet=\"$NTNX - Nutanix +6.5% as bull sees upswing https://seekingalpha.com/news/3477149-nutanixplus-6_5-bull-sees-upswing?source=tweet\" data-url=\"https://seekingalpha.com/news/3477149-nutanixplus-6_5-bull-sees-upswing\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>79&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477147\" data-ts=\"1562854938\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/COST\" target=\"_blank\">COST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477147-costco-momentum-continues-on-wall-street-and-main-street\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Costco momentum continues on Wall Street and Main Street</a></h4><ul> <li>Costco (NASDAQ:<a href='https://seekingalpha.com/symbol/COST' title='Costco Wholesale Corporation'>COST</a>) is <font color=\"green\">up 1.0%</font> after reporting a <a href=\"https://seekingalpha.com/pr/17568174-costco-wholesale-corporation-reports-june-sales-results\" target=\"_blank\">5.4%</a> increase in comparable sales during June, including a 6.3% jump in the U.S. Those marks were right in line with expectations.</li> <li>E-commerce sales were 15.7% higher during the month, a deceleration from the +20% pace for the last six months.</li> <li>On Wall Street, Goldman Sachs reiterated its Buy rating on Costco today and Loop Capital became the first firm with a $300 or higher price target on the retailer.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3477147\" data-linked=\"Costco momentum continues on Wall Street and Main Street\" data-tweet=\"$COST - Costco momentum continues on Wall Street and Main Street https://seekingalpha.com/news/3477147-costco-momentum-continues-on-wall-street-and-main-street?source=tweet\" data-url=\"https://seekingalpha.com/news/3477147-costco-momentum-continues-on-wall-street-and-main-street\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477131\" data-ts=\"1562853314\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVDA\" target=\"_blank\">NVDA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477131-nvidia-upgraded-on-hyperscale-cloud-strength\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nvidia upgraded on hyperscale cloud strength</a></h4><ul><li>Cascend Securities upgrades Nvidia (NASDAQ:<a href='https://seekingalpha.com/symbol/NVDA' title='NVIDIA Corporation'>NVDA</a>) from Hold to Buy with a $190 PT.</li><li>Analyst Eric Ross: \"We see hyperscale Cloud providers starting to come back with orders for components and systems.\"</li><li>Ross thinks Nvidia will provide positive comments in this area and more visibility when it reports earnings on August 15.</li><li>The analyst calls now the \"prime opportunity\" to pick up some shares.</li><li>NVDA shares are <font color=\"green\">up 2.4%</font> to $163.86.</li><li>Nvidia has an Outperform <a href=\"https://seekingalpha.com/symbol/NVDA/ratings/sell-side-ratings\" target=\"_blank\">average Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477131\" data-linked=\"Nvidia upgraded on hyperscale cloud strength\" data-tweet=\"$NVDA - Nvidia upgraded on hyperscale cloud strength https://seekingalpha.com/news/3477131-nvidia-upgraded-on-hyperscale-cloud-strength?source=tweet\" data-url=\"https://seekingalpha.com/news/3477131-nvidia-upgraded-on-hyperscale-cloud-strength\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:55 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>59&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477130\" data-ts=\"1562853285\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EYEN\" target=\"_blank\">EYEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477130-eyenovia-prices-equity-offering-shares-down-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Eyenovia prices equity offering; shares down 10%</a></h4><ul><li>Thinly traded nano cap Eyenovia (<a href='https://seekingalpha.com/symbol/EYEN' title='Eyenovia, Inc.'>EYEN</a> <font color=\"red\">-10%</font>) is down on a 10x surge in volume, albeit on turnover of only 567K shares, in reaction to its <a href=\"https://seekingalpha.com/pr/17569008-eyenovia-inc-prices-public-offering-common-stock\" target=\"_blank\">public offering</a> of ~4.4M common shares at $2.78 per share.</li><li>Underwriters over-allotment is an additional ~658K shares. Closing date is July 15.</li><li>Yesterday's close was $3.09.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477130\" data-linked=\"Eyenovia prices equity offering; shares down 10%\" data-tweet=\"$EYEN - Eyenovia prices equity offering; shares down 10% https://seekingalpha.com/news/3477130-eyenovia-prices-equity-offering-shares-down-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3477130-eyenovia-prices-equity-offering-shares-down-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:54 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477120\" data-ts=\"1562852605\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CATO\" target=\"_blank\">CATO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477120-cato-reports-june-store-sales-up-8\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Cato reports June same-store sales up 8%</a></h4><ul> <li>Cato (<a href='https://seekingalpha.com/symbol/CATO' title='The Cato Corporation'>CATO</a> <font color='green'>+2.9%</font>) <a href=\"https://seekingalpha.com/pr/17568524-cato-reports-june-store-sales-8-percent\" sasource=\"qp_sum_news_1\" target=\"_blank\">reports</a> same-store sales rose 8% in June, exceeded company's expectations</li><li>Total sales up 5% to $76.6M for the month.</li><li>YTD sales fell 1% to $380.7M and same-store sales grew 1%.</li><li>The retailer ended the month with 1,301 stores in operations across 31 states vs. 1,350 stores in 33 states year ago.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477120\" data-linked=\"Cato reports June same-store sales up 8%\" data-tweet=\"$CATO - Cato reports June same-store sales up 8% https://seekingalpha.com/news/3477120-cato-reports-june-store-sales-up-8?source=tweet\" data-url=\"https://seekingalpha.com/news/3477120-cato-reports-june-store-sales-up-8\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477116\" data-ts=\"1562851570\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WBA\" target=\"_blank\">WBA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477116-walgreens-expands-retail-access-to-kaleos-epinephrine\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Walgreens expands retail access to kaléo&#39;s epinephrine</a></h4><ul><li>Walgreens (NASDAQ:<a href='https://seekingalpha.com/symbol/WBA' title='Walgreens Boots Alliance, Inc.'>WBA</a>) <a href=\"https://seekingalpha.com/pr/17568631-walgreens-kaleo-expand-retail-pharmacy-collaboration-include-auvi-q-epinephrine-injection-usp\" target=\"_blank\">announces </a>the availability of privately held kaléo's AUVI-q (epinephrine injection, USP) 0.10 mg auto-injector at its retail pharmacies nationwide. This formulation is the only one approved in the U.S. for treating emergency allergic reactions in infants and toddlers weighing 16.5 - 33 pounds. The product will be available at no cost to commercially insured patients and those eligible for kaléo's patient support programs.</li><li>Walgreens also stocks the 0.15 mg and 0.30 mg formulations for older patients.</li><li>WBA is up <font color=\"green\">2%</font> premarket on the Trump administration's <a href=\"https://seekingalpha.com/news/3477077-white-house-kills-drug-rebate-proposal-healthcare-stocks-rally-premarket\" target=\"_blank\">withdrawal </a>of its proposal to curb PBM drug rebates.</li><li>Competitor Mylan N.V. (NASDAQ:<a href='https://seekingalpha.com/symbol/MYL' title='Mylan N.V.'>MYL</a>) was under pressure yesterday on the continue shortage of EpiPen. Shares are down a fraction premarket.</li><li>Related ticker: Teva Pharmaceutical Industries (NYSE:<a href='https://seekingalpha.com/symbol/TEVA' title='Teva Pharmaceutical Industries Limited'>TEVA</a>) (<font color=\"red\">-1% </font>premarket)</li></ul><div class=\"tiny-share-widget\" data-id=\"3477116\" data-linked=\"Walgreens expands retail access to kaléo&#39;s epinephrine\" data-tweet=\"$WBA $MYL $TEVA - Walgreens expands retail access to kaléo&#39;s epinephrine https://seekingalpha.com/news/3477116-walgreens-expands-retail-access-to-kaleos-epinephrine?source=tweet\" data-url=\"https://seekingalpha.com/news/3477116-walgreens-expands-retail-access-to-kaleos-epinephrine\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477114\" data-ts=\"1562851448\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WW\" target=\"_blank\">WW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477114-weight-watchersplus-6-after-jpmorgan-moves-off-bearish-stance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Weight Watchers +6% after JPMorgan moves off bearish stance</a></h4><ul> <li>JPMorgan lifts Weight Watchers (NASDAQ:<a href='https://seekingalpha.com/symbol/WW' title='Weight Watchers International, Inc.'>WW</a>) to a Neutral rating from Underweight after seeing stabilizing subscriber trends at the company.</li> <li>The firm bumps up its price target to $22 vs. the <a href=\"https://seekingalpha.com/symbol/WW/ratings/sell-side-ratings\" target=\"_blank\">sell-side average PT</a> of $25.45.</li>  <li>Shares of WW are <font color=\"green\">up 6.23%</font> premarket to $23.20 to cut into the 43% YTD decline.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3477114\" data-linked=\"Weight Watchers +6% after JPMorgan moves off bearish stance\" data-tweet=\"$WW - Weight Watchers +6% after JPMorgan moves off bearish stance https://seekingalpha.com/news/3477114-weight-watchersplus-6-after-jpmorgan-moves-off-bearish-stance?source=tweet\" data-url=\"https://seekingalpha.com/news/3477114-weight-watchersplus-6-after-jpmorgan-moves-off-bearish-stance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:24 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477112\" data-ts=\"1562851112\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477112-healthcare-dominate-premarket-gainers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare dominate premarket gainers</a></h4><ul><li>Immunic (NASDAQ:<a href='https://seekingalpha.com/symbol/IMUX' title='Immunic, Inc.'>IMUX</a>) <font color=\"green\">+17%</font>.</li><li>Foresight Autonomous Holdings (NASDAQ:<a href='https://seekingalpha.com/symbol/FRSX' title='Foresight Autonomous Holdings Ltd.'>FRSX</a>) <font color=\"green\">+15%</font>. as its wholly owned subsidiary, Eye-Net Mobile will conduct in Israel <a href=\"https://seekingalpha.com/pr/17568406-eye-net-mobile-announces-large-scale-trial-cellular-based-accident-prevention-solution\" target=\"_blank\">a large-scale trial of its </a><a href=\"https://seekingalpha.com/pr/17568406-eye-net-mobile-announces-large-scale-trial-cellular-based-accident-prevention-solution\" target=\"_blank\">Eye-Net</a>.</li><li>Jaguar Health (NASDAQ:<a href='https://seekingalpha.com/symbol/JAGX' title='Jaguar Health, Inc.'>JAGX</a>) <font color=\"green\">+10%</font> as its wholly owned subsidiary, Napo Pharmaceuticals <a href=\"https://seekingalpha.com/pr/17568984-jaguar-healths-wholly-owned-subsidiary-napo-pharmaceuticals-inc-commits-support-study\" target=\"_blank\">commits</a> to support study evaluating the effect of crofelemer on patients with chronic idiopathic diarrhea</li><li>Cigna (NYSE:<a href='https://seekingalpha.com/symbol/CI' title='Cigna Corporation'>CI</a>) <font color=\"green\">+10%</font> as White House <a href=\"https://seekingalpha.com/news/3477077-white-house-kills-drug-rebate-proposal-healthcare-stocks-rally-premarket\" target=\"_blank\">kills drug rebate proposal</a>.</li><li>Dynavax Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/DVAX' title='Dynavax Technologies Corporation'>DVAX</a>) <font color=\"green\">+10%</font> on <a href=\"https://seekingalpha.com/news/3476975-dynavax-15-percent-hours-bullish-cantor-rating\" target=\"_blank\">bullish Cantor rating</a>.</li><li>Atossa Genetics (NASDAQ:<a href='https://seekingalpha.com/symbol/ATOS' title='Atossa Genetics Inc.'>ATOS</a>) <font color=\"green\">+10%</font> on <a href=\"https://seekingalpha.com/pr/17568825-atossa-genetics-announces-new-proprietary-modified-release-oral-endoxifen-tablet-phase-1\" target=\"_blank\">announcing</a> new proprietary modified-release oral endoxifen tablet; Phase 1 clinical trial initiated.</li><li>Omeros (NASDAQ:<a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a>) <font color=\"green\">+10%</font> as <a href=\"https://seekingalpha.com/news/3477102-fda-board-endpoint-pivot-study-omeros-narsoplimab-shares-12-percent-premarket\" target=\"_blank\">FDA on board</a> with endpoint for pivot study of Omeros' narsoplimab.</li><li>Aquestive Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AQST' title='Aquestive Therapeutics, Inc.'>AQST</a>) <font color=\"green\">+10%</font>.</li><li>Diplomat Pharmacy (NYSE:<a href='https://seekingalpha.com/symbol/DPLO' title='Diplomat Pharmacy, Inc.'>DPLO</a>) <font color=\"green\">+9%</font>.</li><li>CVS Health (NYSE:<a href='https://seekingalpha.com/symbol/CVS' title='CVS Health Corporation'>CVS</a>) <font color=\"green\">+7%</font> as White House <a href=\"https://seekingalpha.com/news/3477077-white-house-kills-drug-rebate-proposal-healthcare-stocks-rally-premarket\" target=\"_blank\">kills drug rebate proposal</a>.</li><li>Tandem Diabetes Care (NASDAQ:<a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a>) <font color=\"green\">+5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477112\" data-linked=\"Healthcare dominate premarket gainers\" data-tweet=\"$IMUX $FRSX $JAGX - Healthcare dominate premarket gainers https://seekingalpha.com/news/3477112-healthcare-dominate-premarket-gainers?source=tweet\" data-url=\"https://seekingalpha.com/news/3477112-healthcare-dominate-premarket-gainers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477109\" data-ts=\"1562850795\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SMAR\" target=\"_blank\">SMAR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477109-smartsheetplus-1_9-on-street-high-target\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Smartsheet +1.9% on Street-high target</a></h4><ul><li>Needham maintains a Buy rating and raises Smartsheet's (NYSE:<a href='https://seekingalpha.com/symbol/SMAR' title='Smartsheet Inc.'>SMAR</a>) PT from $45 to $60.</li><li>Analyst Scott Berg cites increased confidence that SMAR can grow revenue at 40%+ for at least two years.</li><li>Berg praises \"a new M&amp;A war chest and a robust product roadmap,\" which join a solid innovation pace to keep SMAR ahead of less flexible competitors.</li><li>SMAR shares are <font color=\"green\">up 1.9%</font> pre-market to $53.86.</li><li>Smartsheet has an Outperform average <a href=\"https://seekingalpha.com/symbol/SMAR/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477109\" data-linked=\"Smartsheet +1.9% on Street-high target\" data-tweet=\"$SMAR - Smartsheet +1.9% on Street-high target https://seekingalpha.com/news/3477109-smartsheetplus-1_9-on-street-high-target?source=tweet\" data-url=\"https://seekingalpha.com/news/3477109-smartsheetplus-1_9-on-street-high-target\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477107\" data-ts=\"1562850660\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477107-bbby-visl-among-premarket-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BBBY, VISL among premarket losers</a></h4><ul><li>Vislink Technologies (NASDAQ:<a href='https://seekingalpha.com/symbol/VISL' title='Vislink Technologies, Inc.'>VISL</a>) <font color=\"red\">-31%</font> on <a href=\"https://seekingalpha.com/news/3476999-vislink-minus-13_2-percent-filing-offer-7_27m-shares\" target=\"_blank\">filing</a> to offer 7.27M shares.</li><li>Camber Energy (NYSEMKT:<a href='https://seekingalpha.com/symbol/CEI' title='Camber Energy, Inc.'>CEI</a>) <font color=\"red\">-10%</font>.</li><li>Leap Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/LPTX' title='Leap Therapeutics, Inc.'>LPTX</a>) <font color=\"red\">-10%</font> on <a href=\"https://seekingalpha.com/pr/17568666-leap-therapeutics-announces-common-stock-purchase-agreements-21-million-lincoln-park-capital\" target=\"_blank\">announcing</a> stock purchase agreements for up to $21M.</li><li>Amyris (NASDAQ:<a href='https://seekingalpha.com/symbol/AMRS' title='Amyris, Inc.'>AMRS</a>) <font color=\"red\">-10%</font>.</li><li>Eyenovia (NASDAQ:<a href='https://seekingalpha.com/symbol/EYEN' title='Eyenovia, Inc.'>EYEN</a>) <font color=\"red\">-10%</font> on <a href=\"https://seekingalpha.com/news/3476939-eyenovia-5-percent-hours-equity-offering\" target=\"_blank\">equity offering</a>.</li><li>Bed Bath &amp; Beyond (NASDAQ:<a href='https://seekingalpha.com/symbol/BBBY' title='Bed Bath & Beyond Inc.'>BBBY</a>) <font color=\"red\">-6%</font> on <a href=\"https://seekingalpha.com/news/3476940-bed-bath-and-beyond-eps-beats-0_04-misses-revenue\" target=\"_blank\">Q1 earnings</a>.</li><li>CannTrust Holdings (NYSE:<a href='https://seekingalpha.com/symbol/CTST' title='CannTrust Holdings Inc.'>CTST</a>) <font color=\"red\">-6%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3477107\" data-linked=\"BBBY, VISL among premarket losers\" data-tweet=\"$VISL $CEI $LPTX - BBBY, VISL among premarket losers https://seekingalpha.com/news/3477107-bbby-visl-among-premarket-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3477107-bbby-visl-among-premarket-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:11 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477106\" data-ts=\"1562850635\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LPTX\" target=\"_blank\">LPTX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477106-leap-down-10-premarket-on-discounted-stock-sales-deal\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Leap down 10% premarket on discounted stock sales deal</a></h4><ul><li>Thinly traded nano cap Leap Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/LPTX' title='Leap Therapeutics, Inc.'>LPTX</a>) slips <font color=\"red\">10% </font>premarket on average volume in reaction to stock purchase <a href=\"https://seekingalpha.com/pr/17568666-leap-therapeutics-announces-common-stock-purchase-agreements-21-million-lincoln-park-capital\" target=\"_blank\">agreements </a>with Lincoln Park Capital Fund, LLC.</li><li>A contract inked today specifies the sale of $1M of its common stock at $1.75 per share, 15% below yesterday's close of $2.06.</li><li>A separate agreement gives the company the option to sell up to an additional $20M of stock to Lincoln Park, at its discretion, over a 24-month period at prevailing market prices.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477106\" data-linked=\"Leap down 10% premarket on discounted stock sales deal\" data-tweet=\"$LPTX - Leap down 10% premarket on discounted stock sales deal https://seekingalpha.com/news/3477106-leap-down-10-premarket-on-discounted-stock-sales-deal?source=tweet\" data-url=\"https://seekingalpha.com/news/3477106-leap-down-10-premarket-on-discounted-stock-sales-deal\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477102\" data-ts=\"1562850083\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OMER\" target=\"_blank\">OMER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477102-fda-on-board-endpoint-for-pivot-study-of-omeros-narsoplimab-shares-up-12-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA on board with endpoint for pivot study of Omeros&#39; narsoplimab; shares up 12% premarket</a></h4><ul><li>Omeros (NASDAQ:<a href='https://seekingalpha.com/symbol/OMER' title='Omeros Corporation'>OMER</a>) is up <font color=\"green\">12%</font> premarket on modest volume on the heels of its <a href=\"https://seekingalpha.com/pr/17568657-omeros-announces-agreement-fda-primary-endpoint-narsoplimab-bla-stem-cell-transplant\" target=\"_blank\">announcement </a>that the FDA has agreed on the primary endpoint for its pivotal study evaluating lead candidate narsoplimab (OMS721) for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA), a Breakthrough Therapy-tagged indication.</li><li>The response-based primary endpoint needs to demonstrate a beneficial effect on the underlying HSCT-TMA disease process and a meaningful clinical improvement. It will include laboratory measures, organ function biomarkers and platelet and red blood cell transfusion burden.</li><li>The company says it is confident of a successful outcome.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477102\" data-linked=\"FDA on board with endpoint for pivot study of Omeros&#39; narsoplimab; shares up 12% premarket\" data-tweet=\"$OMER - FDA on board with endpoint for pivot study of Omeros&#39; narsoplimab; shares up 12% premarket https://seekingalpha.com/news/3477102-fda-on-board-endpoint-for-pivot-study-of-omeros-narsoplimab-shares-up-12-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3477102-fda-on-board-endpoint-for-pivot-study-of-omeros-narsoplimab-shares-up-12-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>118&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477100\" data-ts=\"1562849975\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MAN\" target=\"_blank\">MAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477100-manpowergroupminus-2-after-credit-suisse-cut\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">ManpowerGroup -2% after Credit Suisse cut</a></h4><ul> <li>Credit Suisse lowers ManpowerGroup (NYSE:<a href='https://seekingalpha.com/symbol/MAN' title='ManpowerGroup Inc.'>MAN</a>) to an Underperform rating from Neutral due largely to a deteriorating European macro environment and with no incremental buyer seen as supporting share price.</li> <li>The firm lowers its price target to $83 from $88.</li> <li>\"We do not see upside guidance risk despite easier comps given macro headwinds and USD strength (~85% MAN revenue is nondollar),\" warns CS.</li><li>Shares of MAN are <font color=\"red\">down 2.15%</font> premarket to $91.00.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3477100\" data-linked=\"ManpowerGroup -2% after Credit Suisse cut\" data-tweet=\"$MAN - ManpowerGroup -2% after Credit Suisse cut https://seekingalpha.com/news/3477100-manpowergroupminus-2-after-credit-suisse-cut?source=tweet\" data-url=\"https://seekingalpha.com/news/3477100-manpowergroupminus-2-after-credit-suisse-cut\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477097\" data-ts=\"1562849175\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LLY\" target=\"_blank\">LLY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477097-lilly-bio-medicines-chief-to-depart-next-month-shares-down-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Lilly Bio-Medicines chief to depart next month; shares down 3%</a></h4><ul><li>Eli Lilly (NYSE:<a href='https://seekingalpha.com/symbol/LLY' title='Eli Lilly and Company'>LLY</a>) <a href=\"https://seekingalpha.com/pr/17568769-lilly-announces-changes-senior-leadership\" target=\"_blank\">announces </a>that SVP and President Lilly Bio-Medicines Christi Shaw will leave the company at the end of August.</li><li>President &amp; General Manager of Lilly Japan Patrik Jonsson will succeed her.</li><li>SVP and General Counsel Mike Harrington will retire at year-end. A search is underway for a successor.</li><li>Shares are down <font color=\"red\">3%</font> premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477097\" data-linked=\"Lilly Bio-Medicines chief to depart next month; shares down 3%\" data-tweet=\"$LLY - Lilly Bio-Medicines chief to depart next month; shares down 3% https://seekingalpha.com/news/3477097-lilly-bio-medicines-chief-to-depart-next-month-shares-down-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3477097-lilly-bio-medicines-chief-to-depart-next-month-shares-down-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477077\" data-ts=\"1562847489\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UNH\" target=\"_blank\">UNH</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477077-white-house-kills-drug-rebate-proposal-healthcare-stocks-rally-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">White House kills drug rebate proposal, healthcare stocks rally premarket</a></h4><ul><li>Pharmacy benefit managers (PBMs) and other healthcare players are up premarket in reaction to the Trump administration's <a href=\"https://www.axios.com/newsletters/axios-vitals-c38101f0-76f2-46d7-a15b-52cfc8b4ae36.html\" target=\"_blank\">reversal</a> on its proposed overhaul of rebates collected by the drug middlemen.</li><li>At this juncture, the administration is moving forward with its plan to tie Medicare reimbursement for drugs to the lowest prices paid elsewhere. President Trump is expected to use an executive order to implement.</li><li>Selected tickers: UnitedHealth Group (NYSE:<a href='https://seekingalpha.com/symbol/UNH' title='UnitedHealth Group Incorporated'>UNH</a>) (<font color=\"green\">+3%</font>), CVS Health (NYSE:<a href='https://seekingalpha.com/symbol/CVS' title='CVS Health Corporation'>CVS</a>) (<font color=\"green\">+5%</font>), Cigna (NYSE:<a href='https://seekingalpha.com/symbol/CI' title='Cigna Corporation'>CI</a>) (<font color=\"green\">+9%</font>), Humana (NYSE:<a href='https://seekingalpha.com/symbol/HUM' title='Humana Inc.'>HUM</a>) (<font color=\"green\">+2%</font>), Centene (NYSE:<a href='https://seekingalpha.com/symbol/CNC' title='Centene Corporation'>CNC</a>) (<font color=\"green\">+3%</font>), Anthem (NYSE:<a href='https://seekingalpha.com/symbol/ANTM' title='Anthem, Inc.'>ANTM</a>) (<font color=\"green\">+1%</font>), AmerisourceBergen (NYSE:<a href='https://seekingalpha.com/symbol/ABC' title='AmerisourceBergen Corporation'>ABC</a>) (<font color=\"green\">+1%</font>), Cardinal Health (NYSE:<a href='https://seekingalpha.com/symbol/CAH' title='Cardinal Health, Inc.'>CAH</a>) (<font color=\"green\">+3%</font>), McKesson (NYSE:<a href='https://seekingalpha.com/symbol/MCK' title='McKesson Corporation'>MCK</a>) (<font color=\"green\">+3%</font>), Walgreens Boots Alliance (NASDAQ:<a href='https://seekingalpha.com/symbol/WBA' title='Walgreens Boots Alliance, Inc.'>WBA</a>) (<font color=\"green\">+3%</font>), AbbVie (NYSE:<a href='https://seekingalpha.com/symbol/ABBV' title='AbbVie Inc.'>ABBV</a>) (<font color=\"green\">+1%</font>)</li></ul><div class=\"tiny-share-widget\" data-id=\"3477077\" data-linked=\"White House kills drug rebate proposal, healthcare stocks rally premarket\" data-tweet=\"$UNH $CVS $CI - White House kills drug rebate proposal, healthcare stocks rally premarket https://seekingalpha.com/news/3477077-white-house-kills-drug-rebate-proposal-healthcare-stocks-rally-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3477077-white-house-kills-drug-rebate-proposal-healthcare-stocks-rally-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>182&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477076\" data-ts=\"1562847448\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GME\" target=\"_blank\">GME</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477076-gamestopminus-3-after-updating-on-dutch-auction-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">GameStop -3% after updating on Dutch auction results</a></h4><ul> <li>GameStop (NYSE:<a href='https://seekingalpha.com/symbol/GME' title='GameStop Corp.'>GME</a>) announces that it expects to accept 12M shares for payment at a purchase price of $5.20 in its modified Dutch auction.</li>   <li>The aggregate cost to GameStop will be approximately $62.4M excluding fees and expenses relating to the tender offer.  The shares expected to be purchased represent approximately 11.72% of GameStop's Class A common stock issued and outstanding as of July 10.</li><li>GME <font color=\"red\">-3.09%</font> premarket to $5.02.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17568729-gamestop-announces-preliminary-results-modified-dutch-auction-tender-offer\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3477076\" data-linked=\"GameStop -3% after updating on Dutch auction results\" data-tweet=\"$GME - GameStop -3% after updating on Dutch auction results https://seekingalpha.com/news/3477076-gamestopminus-3-after-updating-on-dutch-auction-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3477076-gamestopminus-3-after-updating-on-dutch-auction-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>78&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477075\" data-ts=\"1562847437\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBGI\" target=\"_blank\">SBGI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477075-sinclair-reports-prelim-q2-signs-charter-agreement\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sinclair reports prelim Q2; signs Charter agreement</a></h4><ul><li>Sinclair Broadcasting (NASDAQ:<a href='https://seekingalpha.com/symbol/SBGI' title='Sinclair Broadcast Group, Inc.'>SBGI</a>) <font color=\"red\">-0.4%</font> <a href=\"https://seekingalpha.com/pr/17568617-sinclair-reports-preliminary-second-quarter-2019-media-revenue\" target=\"_blank\">releases</a> preliminary Q2 results with $721M in Media Revenues, which is in-line with the company's $716M to $725M outlook.</li><li>SBGI announces a multi-year pact with Charter Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/CHTR' title='Charter Communications, Inc.'>CHTR</a>) for continuing to carry its broadcast TV and Tennis Channel stations. Charter will also add the Marquee Sports Network when it launches in Q1.</li><li>The agreement provides a term extension for the currently carried FOX regional sports networks, effective after Sinclair finishes acquiring the RSNs from Disney.</li><li>Sinclair will report full Q2 results on August 7.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477075\" data-linked=\"Sinclair reports prelim Q2; signs Charter agreement\" data-tweet=\"$SBGI $SBGI $CHTR - Sinclair reports prelim Q2; signs Charter agreement https://seekingalpha.com/news/3477075-sinclair-reports-prelim-q2-signs-charter-agreement?source=tweet\" data-url=\"https://seekingalpha.com/news/3477075-sinclair-reports-prelim-q2-signs-charter-agreement\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:17 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477073\" data-ts=\"1562847105\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HEI\" target=\"_blank\">HEI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477073-double-downgrade-for-heico-bofa\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Double downgrade for Heico at BofA</a></h4><ul><li>Heico (NYSE:<a href='https://seekingalpha.com/symbol/HEI' title='HEICO Corporation'>HEI</a>) was downgraded two notches to Underperform from Buy at BofA, which sees weaker than average air traffic growth as a yellow flag of caution for the commercial aerospace cycle.</li><li>\"We have now seen four consecutive months of air traffic growth below the six year average of 6.4% and three consecutive months of sub-5% growth,\" wrote analyst Ronald Epstein, who kept his PT at $105.</li><li>Air traffic growth from the International Air Transport Association slowed again in May 2019 with only a 4.5% growth in revenue passenger kilometers, a measure of air traffic.</li><li>HEI <font color=\"red\">-2.5%</font> premarket</li><li>Source: Bloomberg First Word</li></ul><div class=\"tiny-share-widget\" data-id=\"3477073\" data-linked=\"Double downgrade for Heico at BofA\" data-tweet=\"$HEI $HEI.A - Double downgrade for Heico at BofA https://seekingalpha.com/news/3477073-double-downgrade-for-heico-bofa?source=tweet\" data-url=\"https://seekingalpha.com/news/3477073-double-downgrade-for-heico-bofa\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:11 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477072\" data-ts=\"1562846977\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CMA\" target=\"_blank\">CMA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477072-bofa-outlook-on-regional-banks-dims-comerica-cullen-frost-fall\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BofA outlook on regional banks dims; Comerica, Cullen/Frost fall</a></h4><ul><li>Comerica (NYSE:<a href='https://seekingalpha.com/symbol/CMA' title='Comerica Incorporated'>CMA</a>) <font color=\"red\">slides 2.0%</font> in premarket trading and Cullen/Frost Bankers (NYSE:<a href='https://seekingalpha.com/symbol/CFR' title='Cullen/Frost Bankers, Inc.'>CFR</a>) <font color=\"red\">slips 1.1%</font> after Bank of America cuts the stocks, along with Regions Financial (NYSE:<a href='https://seekingalpha.com/symbol/RF' title='Regions Financial Corporation'>RF</a>) and Hancock Whitney (NASDAQ:<a href='https://seekingalpha.com/symbol/HWC' title='Hancock Whitney Corporation'>HWC</a>), on a cloudier EPS outlook as the Fed's poised to cut rates three times through March 2020.</li><li>CMA cut two notches to underperform; Cullen/Frost downgraded to underperform; Regions and Hancock Whitney to neutral.</li><li>For Q2, BofA analyst Erika Najarian expects banks to meet bottom-line estimates as loan growth offsets net interest margin pressure; provisions may come in better than expected due to \"solid\" credit quality.</li><li>Regions -0.5%.</li><li>Comerica quant rating <a href=\"https://seekingalpha.com/symbol/CMA/ratings/quant-ratings\" target=\"_blank\">Neutral</a>; Sell-Side average rating <a href=\"https://seekingalpha.com/symbol/CMA/ratings/sell-side-ratings?s=cma\" target=\"_blank\">Hold</a> (6 Buy, 4 Outperform, 16 Hold, 2 Underperform, 1 Sell).</li><li>Cullen/Frost Bankers quant rating <a href=\"https://seekingalpha.com/symbol/CFR/ratings/quant-ratings\" target=\"_blank\">Bearish</a>; Sell-Side average rating <a href=\"https://seekingalpha.com/symbol/CFR/ratings/sell-side-ratings\" target=\"_blank\">Hold </a>(1 Buy, 1 Outperform, 10 Hold, 2 Underperform, 1 Sell).</li></ul><div class=\"tiny-share-widget\" data-id=\"3477072\" data-linked=\"BofA outlook on regional banks dims; Comerica, Cullen/Frost fall\" data-tweet=\"$CMA $CFR $RF - BofA outlook on regional banks dims; Comerica, Cullen/Frost fall https://seekingalpha.com/news/3477072-bofa-outlook-on-regional-banks-dims-comerica-cullen-frost-fall?source=tweet\" data-url=\"https://seekingalpha.com/news/3477072-bofa-outlook-on-regional-banks-dims-comerica-cullen-frost-fall\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:09 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477068\" data-ts=\"1562846750\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IRM\" target=\"_blank\">IRM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477068-bofaml-questions-irms-bold-strategy\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">BofAML questions IRM&#39;s &#39;bold&#39; strategy</a></h4><ul><li>Bank of America Merrill Lynch cuts Iron Mountain (NYSE:<a href='https://seekingalpha.com/symbol/IRM' title='Iron Mountain Incorporated'>IRM</a>) from Neutral to Underperform and lowers the target from $33 to $25, a 22% downside.</li><li>Analyst Michael Funk says declining recycled paper prices create \"insurmountable headwinds\" to 2019 guidance.</li><li>Funk notes that IRM is pursuing a \"bold\" strategy of shifting the mix to the higher-growth data centers and emerging markets.</li><li>The analyst expects negative estimate revisions.</li><li>IRM <a href=\"https://seekingalpha.com/symbol/IRM/earnings\" target=\"_blank\">reports earnings</a> on August 1 with consensus estimates expecting $1.07B in revenue and $0.50 FFO.</li><li>Iron Mountain has a Hold average <a href=\"https://seekingalpha.com/symbol/IRM/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477068\" data-linked=\"BofAML questions IRM&#39;s &#39;bold&#39; strategy\" data-tweet=\"$IRM - BofAML questions IRM&#39;s &#39;bold&#39; strategy https://seekingalpha.com/news/3477068-bofaml-questions-irms-bold-strategy?source=tweet\" data-url=\"https://seekingalpha.com/news/3477068-bofaml-questions-irms-bold-strategy\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>159&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477067\" data-ts=\"1562846586\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGY\" target=\"_blank\">MGY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477067-magnolia-oil-gas-completes-exchange-offer\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Magnolia Oil &amp; Gas completes exchange offer</a></h4><ul><li>Magnolia Oil &amp; Gas (NYSE:<a href='https://seekingalpha.com/symbol/MGY' title='Magnolia Oil & Gas Corporation'>MGY</a>) <font color=\"red\">-3%</font> pre-market after filing for an <a href=\"https://www.sec.gov/Archives/edgar/data/1698990/000104746919004093/a2239239zs-3.htm\" target=\"_blank\">offering</a> of more than 9.7M common shares by selling shareholders; the company will receive no proceeds from the sale.</li><li>MGY also announces the <a href=\"https://seekingalpha.com/pr/17568185-magnolia-oil-and-gas-corporation-announces-completion-exchange-offer-plan-exchange-remaining\" target=\"_blank\">completion and settlement</a> of its previously announced exchange offer and consent solicitation relating to its outstanding warrants.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477067\" data-linked=\"Magnolia Oil &amp; Gas completes exchange offer\" data-tweet=\"$MGY - Magnolia Oil &amp; Gas completes exchange offer https://seekingalpha.com/news/3477067-magnolia-oil-gas-completes-exchange-offer?source=tweet\" data-url=\"https://seekingalpha.com/news/3477067-magnolia-oil-gas-completes-exchange-offer\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:03 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477066\" data-ts=\"1562846511\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RYAAY\" target=\"_blank\">RYAAY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477066-ryanair-warns-on-737-max-delivery-delay\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ryanair warns on 737 Max delivery delay</a></h4><ul> <li>Ryanair (NASDAQ:<a href='https://seekingalpha.com/symbol/RYAAY' title='Ryanair Holdings plc'>RYAAY</a>) CEO Michael O'Leary says the <a href=\"https://www.reuters.com/article/us-ryanair-hldgs-boeing-737/ryanair-sees-risk-to-2020-growth-if-737-max-grounded-beyond-november-idUSKCN1U52ME\" target=\"_blank\">negative impact</a> of the Boeing 737 MAX grounding on the airline's growth plans may start to spill over to next summer if the airplane isn't flying again by this fall.</li> <li>He notes the airline might have to cut capacity if the expected delivery of 50 737 Max jets is pushed off until past November when summertime schedules are worked out.</li> <li>O'Leary says he takes comfort from the fact that it seems U.S, European, Brazilian and Canadian regulators are now working together.</li> <li>Shares of Ryanair are <font color=\"red\">down 2.00%</font> in Dublin trading.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3477066\" data-linked=\"Ryanair warns on 737 Max delivery delay\" data-tweet=\"$RYAAY - Ryanair warns on 737 Max delivery delay https://seekingalpha.com/news/3477066-ryanair-warns-on-737-max-delivery-delay?source=tweet\" data-url=\"https://seekingalpha.com/news/3477066-ryanair-warns-on-737-max-delivery-delay\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477065\" data-ts=\"1562846393\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNSS\" target=\"_blank\">SNSS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477065-sunesis-prices-stock-offering-shares-down-27-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sunesis prices stock offering; shares down 27% premarket</a></h4><ul> <li>Sunesis Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SNSS' title='Sunesis Pharmaceuticals, Inc.'>SNSS</a>) has <a href=\"https://seekingalpha.com/pr/17568393-sunesis-announces-pricing-25-million-offering-securities\" target=\"_blank\">priced</a> its public offerings of 33,333,667 common shares and 8,333 shares of non-voting Series F Convertible Preferred Stock, at $0.60 and $600 per share, respectively, for combined gross proceeds of ~$25M. Each Series F Share is convertible into 1,000 common shares.</li>   <li>Underwriters over-allotment is an additional 5,000,050 common shares.</li>  <li>Net proceeds will be used to fund development of vecabrutinib, ongoing R&amp;D and general corporate purposes.</li><li>Closing date is July 15.</li><li>Shares are down <font color=\"red\">27%</font> premarket.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3476958-sunesis-readies-stock-offering-shares-27-percent-hours\" target=\"_blank\">Sunesis readies stock offering; shares down 27% after hours</a> (July 10)</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3477065\" data-linked=\"Sunesis prices stock offering; shares down 27% premarket\" data-tweet=\"$SNSS - Sunesis prices stock offering; shares down 27% premarket https://seekingalpha.com/news/3477065-sunesis-prices-stock-offering-shares-down-27-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3477065-sunesis-prices-stock-offering-shares-down-27-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:59 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477064\" data-ts=\"1562846245\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FAST\" target=\"_blank\">FAST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477064-fastenal-slips-6-amid-slowing-activity\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fastenal slips 6% amid &#39;slowing&#39; activity</a></h4><ul><li>Diluted net earnings per share were $0.36 vs. $0.37 during the first quarter of 2018, a decrease of 3.2%.</li><li>\"While general economic activity remained positive, we did see slowing in  the second quarter of 2019 relative to activity levels experienced in  the first quarter of 2019,\" the company wrote in a <a href=\"https://seekingalpha.com/pr/17568505-fastenal-company-reports-2019-second-quarter-earnings\" target=\"_blank\">press release</a>.</li><li>Daily sales of fastener products grew 5.5%. Sales of non-fastener products represented 65.5% of sales and grew 9.5% on a daily basis.</li><li>Signed 5,439 industrial vending devices, resulting in an installed device count of 85,871, an increase of 12.9% over June 30, 2018.</li><li>Fastenal also signed 94 new Onsite locations in Q1, resulting in 1,026 active sites on June 30, and representing an increase of 34.8% from a year ago.</li><li><a href='https://seekingalpha.com/symbol/FAST' title='Fastenal Company'>FAST</a> <font color=\"red\">-6.2%</font> premarket</li><li><a href=\"https://seekingalpha.com/news/3477032-fastenal-eps-misses-0_01-misses-revenue\" target=\"_blank\">Q2 results</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3477064\" data-linked=\"Fastenal slips 6% amid &#39;slowing&#39; activity\" data-tweet=\"$FAST - Fastenal slips 6% amid &#39;slowing&#39; activity https://seekingalpha.com/news/3477064-fastenal-slips-6-amid-slowing-activity?source=tweet\" data-url=\"https://seekingalpha.com/news/3477064-fastenal-slips-6-amid-slowing-activity\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>13&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477062\" data-ts=\"1562845713\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MUX\" target=\"_blank\">MUX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477062-mcewen-mining-flags-potential-new-production-source\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">McEwen Mining flags potential new production source</a></h4><ul><li>McEwen Mining (NYSE:<a href='https://seekingalpha.com/symbol/MUX' title='McEwen Mining Inc.'>MUX</a>) <font color=\"green\">+2.9%</font> pre-market after reporting <a href=\"https://seekingalpha.com/pr/17568238-mcewen-mining-exploration-drives-potential-new-source-production\" target=\"_blank\">positive exploration results</a> from the 147NE Target, which it says further define new near surface mineralization.</li><li>Key observations include that the 147NE Target extends from surface to 250 m  and is potentially accessible via a ramp from surface; mineralization widens significantly up to 36 m in areas where structures intersect volcanic  flows; and is in close proximity to three  other deposits in the Grey Fox Area.</li><li>147NE is one of two targets and three deposits that comprise MUX's Grey Fox Area; the deposits cumulatively host an estimated indicated resource of 465K oz. of gold (2.2M metric tons at an average grade of 6.64 g/t).</li></ul><div class=\"tiny-share-widget\" data-id=\"3477062\" data-linked=\"McEwen Mining flags potential new production source\" data-tweet=\"$MUX - McEwen Mining flags potential new production source https://seekingalpha.com/news/3477062-mcewen-mining-flags-potential-new-production-source?source=tweet\" data-url=\"https://seekingalpha.com/news/3477062-mcewen-mining-flags-potential-new-production-source\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:48 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477060\" data-ts=\"1562845642\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TTWO\" target=\"_blank\">TTWO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477060-take-two-cut-on-tough-comps-sharesminus-1_2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Take-Two cut on tough comps; shares -1.2%</a></h4><ul><li>Jefferies downgrades Take-Two (NASDAQ:<a href='https://seekingalpha.com/symbol/TTWO' title='Take-Two Interactive Software, Inc.'>TTWO</a>) from Buy to Hold and lowers the target from $135 to $115.</li><li>Analyst Timothy O'Shea says TTWO is in a \"soft spot\" regarding its game release schedule, and that lack of near-term catalyst makes it harder to \"push the multiple much higher at these levels.\"</li><li>The analyst does praise Take-Two for having the \"most high quality content amongst the U.S. publishers.\"</li><li>TTWO shares are <font color=\"red\">down 1.2%</font> pre-market to $115.85.</li><li>Take-Two has a Neutral <a href=\"https://seekingalpha.com/symbol/TTWO/ratings/quant-ratings\" target=\"_blank\">Quant rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477060\" data-linked=\"Take-Two cut on tough comps; shares -1.2%\" data-tweet=\"$TTWO - Take-Two cut on tough comps; shares -1.2% https://seekingalpha.com/news/3477060-take-two-cut-on-tough-comps-sharesminus-1_2?source=tweet\" data-url=\"https://seekingalpha.com/news/3477060-take-two-cut-on-tough-comps-sharesminus-1_2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:47 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477058\" data-ts=\"1562845250\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WYNN\" target=\"_blank\">WYNN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477058-major-wynn-palace-expansion-in-works\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Major Wynn Palace expansion in the works</a></h4><ul> <li>Wynn Resorts (NASDAQ:<a href='https://seekingalpha.com/symbol/WYNN' title='Wynn Resorts, Limited'>WYNN</a>) announces a <a href=\"http://www.ggrasia.com/wynn-resorts-unveils-us2bln-wynn-palace-extension/\" target=\"_blank\">$2B</a> expansion of its Wynn Palace property in Macau.</li> <li>The 36-month construction project is expected to break ground in the late part of 2021 and attract 7M to 10M visitors annually.</li> <li>Wynn says the targeted return on invested capital was 15% to 20% EBITDA growth.</li><li>Shares of Wynn are up 0.74% premarket to $131.30.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3476800-wynn-resorts-sets-targets-investor-day-event\" target=\"_blank\">Wynn Resorts sets targets at investor day event</a> (July 10)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3477058\" data-linked=\"Major Wynn Palace expansion in the works\" data-tweet=\"$WYNN - Major Wynn Palace expansion in the works https://seekingalpha.com/news/3477058-major-wynn-palace-expansion-in-works?source=tweet\" data-url=\"https://seekingalpha.com/news/3477058-major-wynn-palace-expansion-in-works\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:40 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477050\" data-ts=\"1562844574\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKE\" target=\"_blank\">BKE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477050-buckleplus-4-after-strong-june-sales-print\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Buckle +4% after strong June sales print</a></h4><ul> <li>Buckle (NYSE:<a href='https://seekingalpha.com/symbol/BKE' title='The Buckle, Inc.'>BKE</a>) <a href=\"https://seekingalpha.com/pr/17568504-buckle-inc-reports-june-2019-net-sales\" target=\"_blank\">reports</a> sales rose 5.5% in June to $74.8M.</li> <li>Comparable sales were up 6.2% during the month and are 0.4% higher YTD.</li> <li>Shares of Buckle are <font color=\"green\">up 4.17%</font> in premarket action to $17.73.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3477050\" data-linked=\"Buckle +4% after strong June sales print\" data-tweet=\"$BKE - Buckle +4% after strong June sales print https://seekingalpha.com/news/3477050-buckleplus-4-after-strong-june-sales-print?source=tweet\" data-url=\"https://seekingalpha.com/news/3477050-buckleplus-4-after-strong-june-sales-print\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477047\" data-ts=\"1562844077\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JBLU\" target=\"_blank\">JBLU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477047-jetblue-posts-in-line-unit-revenue-forecast\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">JetBlue posts in-line unit revenue forecast</a></h4><ul> <li>JetBlue (NASDAQ:<a href='https://seekingalpha.com/symbol/JBLU' title='JetBlue Airways Corporation'>JBLU</a>) reports traffic increased 4.7% in June on a capacity increase of 4.8%.</li><li>The airline's load factor for the month fell 10 bps to 86.9%.</li>  <li>JetBlue expects to reports Q2 revenue per available seat mile growth of 3.1% to fall comfortably inside the guidance range of +2.0% to +4.0%.</li><li>JBLU  <font color=\"green\">+1.16%</font> after hours to  $19.16.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17568517-jetblue-airways-reports-june-traffic\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3477047\" data-linked=\"JetBlue posts in-line unit revenue forecast\" data-tweet=\"$JBLU - JetBlue posts in-line unit revenue forecast https://seekingalpha.com/news/3477047-jetblue-posts-in-line-unit-revenue-forecast?source=tweet\" data-url=\"https://seekingalpha.com/news/3477047-jetblue-posts-in-line-unit-revenue-forecast\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:21 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477045\" data-ts=\"1562843969\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNAP\" target=\"_blank\">SNAP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477045-snapplus-1_4-on-bofa-boost-for-user-growth\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Snap +1.4% on BofA boost for user growth</a></h4><ul><li>Bank of America Merrill Lynch maintains a Neutral rating on Snap (NYSE:<a href='https://seekingalpha.com/symbol/SNAP' title='Snap Inc.'>SNAP</a>) but increases the PT from $12 to $17.</li><li>Analyst Justin Post: \"We sense more optimism on Snap\u2019s innovation and less concern on user trends.\"</li><li>Post says SensorTower data shows Snap ended Q2 with downloads +67% Y/Y and +64% sequentially.</li><li>BofA is constructive on Snap's long-term opportunity to monetize users who spend over the 30 minutes a day on the app but is concerned about high expectations and competitive pressure.</li><li>Snap is <a href=\"https://seekingalpha.com/symbol/SNAP/earnings\" target=\"_blank\">expected</a> to report earnings on July 22.</li><li>SNAP is <font color=\"green\">up 1.4%</font> pre-market to $15.47.</li><li>The company has a Hold average <a href=\"https://seekingalpha.com/symbol/SNAP/ratings/sell-side-ratings\" target=\"_blank\">Sell Side rating</a>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477045\" data-linked=\"Snap +1.4% on BofA boost for user growth\" data-tweet=\"$SNAP - Snap +1.4% on BofA boost for user growth https://seekingalpha.com/news/3477045-snapplus-1_4-on-bofa-boost-for-user-growth?source=tweet\" data-url=\"https://seekingalpha.com/news/3477045-snapplus-1_4-on-bofa-boost-for-user-growth\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:19 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477040\" data-ts=\"1562843410\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DAL\" target=\"_blank\">DAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477040-delta-air-linesplus-2-after-profit-beat\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Delta Air Lines +2% after profit beat</a></h4><ul> <li>Delta (NYSE:<a href='https://seekingalpha.com/symbol/DAL' title='Delta Air Lines, Inc.'>DAL</a>) jumps in early trading after raising its full-year profit forecast.</li> <li>The airline carrier anticipates revenue growth of 6% to 7% for the full year and Q3 EPS of $6.75 to $7.25 vs. $6.00 to $7.00 prior and $6.97 consensus.</li> <li>Unit revenue growth of 1.5% to 3.5% is anticipated for Q3.</li> <li>Delta management says the company is benefiting from a multiyear pipeline of fleet, product and loyalty initiatives. Higher revenue from premium seating and corporate travel is also helping to boost sales.</li> <li>Shares of Delta are <font color=\"green\">up 2.15%</font> premarket to $60.75.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3477037-delta-air-lines-eps-beats-0_07-revenue-line\" target=\"_blank\">Delta Air Lines EPS beats by $0.07,  revenue in-line</a> (July 11)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3477040\" data-linked=\"Delta Air Lines +2% after profit beat\" data-tweet=\"$DAL - Delta Air Lines +2% after profit beat https://seekingalpha.com/news/3477040-delta-air-linesplus-2-after-profit-beat?source=tweet\" data-url=\"https://seekingalpha.com/news/3477040-delta-air-linesplus-2-after-profit-beat\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477039\" data-ts=\"1562843285\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SPPI\" target=\"_blank\">SPPI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477039-rbc-softens-view-on-endo-in-premarket-analyst-action\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RBC softens view on Endo in premarket analyst action</a></h4><ul><li>Spectrum Pharmaceuticals (NASDAQ:<a href='https://seekingalpha.com/symbol/SPPI' title='Spectrum Pharmaceuticals, Inc.'>SPPI</a>) initiated with Buy rating and $18 (114% upside) price target at B. Riley FBR. Shares up <font color=\"green\">1% </font>premarket.</li><li>Immunic (NASDAQ:<a href='https://seekingalpha.com/symbol/IMUX' title='Immunic, Inc.'>IMUX</a>) initiated with Buy rating and $40 (266% upside) price target at Chardan Capital Markets. Shares up <font color=\"green\">1% </font>premarket.</li><li>Navidea Biopharmaceuticals (NYSEMKT:<a href='https://seekingalpha.com/symbol/NAVB' title='Navidea Biopharmaceuticals, Inc.'>NAVB</a>) initiated with Buy rating and $2 (233% upside) price target at Maxim Group.</li><li>Amneal Pharmaceuticals (NYSE:<a href='https://seekingalpha.com/symbol/AMRX' title='Amneal Pharmaceuticals, Inc.'>AMRX</a>) downgraded to Sector Perform with a $6 (38% upside) price target at RBC. Shares down <font color=\"red\">4%</font> premarket.</li><li>Endo International (NASDAQ:<a href='https://seekingalpha.com/symbol/ENDP' title='Endo International plc'>ENDP</a>) downgraded to Sector Perform with a $6 (43% upside) price target at RBC citing uncertainty with its financial exposure related to the U.S. opioid epidemic. Shares down <font color=\"red\">2% </font>premarket.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477039\" data-linked=\"RBC softens view on Endo in premarket analyst action\" data-tweet=\"$SPPI $IMUX $AMRX - RBC softens view on Endo in premarket analyst action https://seekingalpha.com/news/3477039-rbc-softens-view-on-endo-in-premarket-analyst-action?source=tweet\" data-url=\"https://seekingalpha.com/news/3477039-rbc-softens-view-on-endo-in-premarket-analyst-action\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3477019\" data-ts=\"1562835531\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BTC-USD\" target=\"_blank\">BTC-USD</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3477019-bitcoin-tumbles-fed-raises-libra-concerns\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bitcoin tumbles as Fed raises Libra concerns</a></h4><ul><li>Are 10% moves for Bitcoin (<a href='https://seekingalpha.com/symbol/BTC-USD' title='Bitcoin USD'>BTC-USD</a>) still newsworthy? Probably not, but uncertainty in the crypto space definitely made headlines after Jerome Powell <a href=\"https://seekingalpha.com/news/3476846-fed-serious-concerns-facebook-libra-powell\" target=\"_blank\">said</a> Facebook's Libra offering should \"not go forward\" without addressing concerns.</li><li>Those include privacy, money laundering, consumer protection and financial stability, the Fed Chair declared during his semi-annual testimony before the House Financial Services Committee.</li><li>The crypto shed close to $1500 to the mid-$11K level following the comments, which echoed a growing chorus of doubts about Libra from authorities around the world.</li></ul><div class=\"tiny-share-widget\" data-id=\"3477019\" data-linked=\"Bitcoin tumbles as Fed raises Libra concerns\" data-tweet=\"$BTC-USD - Bitcoin tumbles as Fed raises Libra concerns https://seekingalpha.com/news/3477019-bitcoin-tumbles-fed-raises-libra-concerns?source=tweet\" data-url=\"https://seekingalpha.com/news/3477019-bitcoin-tumbles-fed-raises-libra-concerns\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:58 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>28&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":71,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}